JPH0696562B2 - Process for producing aminothiadiazoleacetic acid derivative - Google Patents
Process for producing aminothiadiazoleacetic acid derivativeInfo
- Publication number
- JPH0696562B2 JPH0696562B2 JP4769486A JP4769486A JPH0696562B2 JP H0696562 B2 JPH0696562 B2 JP H0696562B2 JP 4769486 A JP4769486 A JP 4769486A JP 4769486 A JP4769486 A JP 4769486A JP H0696562 B2 JPH0696562 B2 JP H0696562B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- salt
- reaction
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title description 24
- YITPIBMUINBXFJ-UHFFFAOYSA-N 2-(5-aminothiadiazol-4-yl)acetic acid Chemical class NC=1SN=NC=1CC(O)=O YITPIBMUINBXFJ-UHFFFAOYSA-N 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims description 78
- 150000003839 salts Chemical class 0.000 claims description 70
- 150000002430 hydrocarbons Chemical group 0.000 claims description 12
- 125000002252 acyl group Chemical group 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 10
- 238000006386 neutralization reaction Methods 0.000 claims description 10
- 238000005917 acylation reaction Methods 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- -1 cephalosporin compounds Chemical class 0.000 description 233
- 238000006243 chemical reaction Methods 0.000 description 69
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- 239000002904 solvent Substances 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 23
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 125000004432 carbon atom Chemical group C* 0.000 description 21
- 238000001816 cooling Methods 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 19
- 239000002585 base Substances 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 17
- 239000002253 acid Substances 0.000 description 17
- 125000003277 amino group Chemical group 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 239000010410 layer Substances 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 150000001408 amides Chemical class 0.000 description 13
- 150000002148 esters Chemical class 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 125000000623 heterocyclic group Chemical group 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 229910052783 alkali metal Inorganic materials 0.000 description 11
- 125000003545 alkoxy group Chemical group 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 10
- 125000005843 halogen group Chemical group 0.000 description 10
- 235000011121 sodium hydroxide Nutrition 0.000 description 10
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 10
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 9
- 150000008065 acid anhydrides Chemical class 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 150000007522 mineralic acids Chemical class 0.000 description 9
- 239000012046 mixed solvent Substances 0.000 description 9
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 9
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 150000007524 organic acids Chemical class 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 239000001632 sodium acetate Substances 0.000 description 8
- 235000017281 sodium acetate Nutrition 0.000 description 8
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 7
- 150000001340 alkali metals Chemical class 0.000 description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 150000002576 ketones Chemical class 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 235000017550 sodium carbonate Nutrition 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 229930186147 Cephalosporin Natural products 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 6
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 229940124587 cephalosporin Drugs 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 150000007529 inorganic bases Chemical class 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 150000002825 nitriles Chemical class 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 235000011181 potassium carbonates Nutrition 0.000 description 6
- 235000011118 potassium hydroxide Nutrition 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 5
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical group NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 125000000392 cycloalkenyl group Chemical group 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 150000002170 ethers Chemical class 0.000 description 5
- 150000008282 halocarbons Chemical class 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229960003975 potassium Drugs 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 4
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 4
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 4
- 125000005915 C6-C14 aryl group Chemical group 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 4
- 150000001342 alkaline earth metals Chemical class 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 4
- 125000003282 alkyl amino group Chemical group 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 235000010216 calcium carbonate Nutrition 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 229960000956 coumarin Drugs 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 235000006408 oxalic acid Nutrition 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 150000007970 thio esters Chemical class 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 3
- OSIJZKVBQPTIMT-KRXBUXKQSA-N (2e)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetic acid Chemical compound CO\N=C(\C(O)=O)C1=NSC(N)=N1 OSIJZKVBQPTIMT-KRXBUXKQSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- IAOWYRAKLUVLHT-UHFFFAOYSA-N 3-(5-amino-1,2,4-thiadiazol-3-yl)chromen-2-one Chemical compound S1C(N)=NC(C=2C(OC3=CC=CC=C3C=2)=O)=N1 IAOWYRAKLUVLHT-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 239000012670 alkaline solution Substances 0.000 description 3
- 125000005210 alkyl ammonium group Chemical group 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 3
- PMOWTIHVNWZYFI-WAYWQWQTSA-N cis-2-coumaric acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1O PMOWTIHVNWZYFI-WAYWQWQTSA-N 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 229960002598 fumaric acid Drugs 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 230000002140 halogenating effect Effects 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 229960002510 mandelic acid Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 150000002960 penicillins Chemical class 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- BWYYVSNVUCFQQN-UHFFFAOYSA-N 1,3-diphenylpropan-2-amine Chemical class C=1C=CC=CC=1CC(N)CC1=CC=CC=C1 BWYYVSNVUCFQQN-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- KQDCFQVCBUSXDC-UHFFFAOYSA-N 2-(5-amino-1,2,4-thiadiazol-3-yl)-2-oxoacetic acid Chemical compound NC1=NC(C(=O)C(O)=O)=NS1 KQDCFQVCBUSXDC-UHFFFAOYSA-N 0.000 description 2
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 2
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical compound [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 125000005914 C6-C14 aryloxy group Chemical group 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 125000001691 aryl alkyl amino group Chemical group 0.000 description 2
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 2
- 125000001769 aryl amino group Chemical group 0.000 description 2
- 125000004658 aryl carbonyl amino group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 2
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 description 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 description 2
- 125000005366 cycloalkylthio group Chemical group 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical class CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical compound O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 2
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 2
- OXQMIXBVXHWDPX-UHFFFAOYSA-N n,n,2-trimethylpropan-2-amine Chemical class CN(C)C(C)(C)C OXQMIXBVXHWDPX-UHFFFAOYSA-N 0.000 description 2
- WWECJGLXBSQKRF-UHFFFAOYSA-N n,n-dimethylformamide;methanol Chemical compound OC.CN(C)C=O WWECJGLXBSQKRF-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 2
- 229940116357 potassium thiocyanate Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 150000003248 quinolines Chemical class 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 125000004149 thio group Chemical group *S* 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- KPGQMAZFCDQQQK-XNWCZRBMSA-N (2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl chloride Chemical compound CO\N=C(/C(Cl)=O)C1=NSC(N)=N1 KPGQMAZFCDQQQK-XNWCZRBMSA-N 0.000 description 1
- PBZUAIHRZUBBAJ-IWQZZHSRSA-N (2z)-2-hydroxyiminoacetic acid Chemical class O\N=C/C(O)=O PBZUAIHRZUBBAJ-IWQZZHSRSA-N 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical compound C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- ILROLYQPRYHHFG-UHFFFAOYSA-N 1-$l^{1}-oxidanylprop-2-en-1-one Chemical group [O]C(=O)C=C ILROLYQPRYHHFG-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 1
- JQCSUVJDBHJKNG-UHFFFAOYSA-N 1-methoxy-ethyl Chemical group C[CH]OC JQCSUVJDBHJKNG-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- LYUPJHVGLFETDG-UHFFFAOYSA-N 1-phenylbutan-2-ol Chemical compound CCC(O)CC1=CC=CC=C1 LYUPJHVGLFETDG-UHFFFAOYSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- NDVMCQUOSYOQMZ-UHFFFAOYSA-N 2,2-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)C(C(N)=O)[Si](C)(C)C NDVMCQUOSYOQMZ-UHFFFAOYSA-N 0.000 description 1
- OTTXCOAOKOEENK-UHFFFAOYSA-N 2,2-difluoroethenone Chemical group FC(F)=C=O OTTXCOAOKOEENK-UHFFFAOYSA-N 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 1
- ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 description 1
- WDRFYIPWHMGQPN-UHFFFAOYSA-N 2-chloroisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Cl)C(=O)C2=C1 WDRFYIPWHMGQPN-UHFFFAOYSA-N 0.000 description 1
- ADDBAPLLQRBDLT-UHFFFAOYSA-N 2-ethoxyiminoacetic acid Chemical compound CCON=CC(O)=O ADDBAPLLQRBDLT-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- SDXAWLJRERMRKF-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazole Chemical compound CC=1C=C(C)NN=1 SDXAWLJRERMRKF-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- XRHGYUZYPHTUJZ-UHFFFAOYSA-N 4-chlorobenzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1 XRHGYUZYPHTUJZ-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001510512 Chlamydia phage 2 Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 150000001555 benzenes Chemical group 0.000 description 1
- DUXANUSOCMOJSI-UHFFFAOYSA-N benzhydryl carbamate Chemical compound C=1C=CC=CC=1C(OC(=O)N)C1=CC=CC=C1 DUXANUSOCMOJSI-UHFFFAOYSA-N 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- AQIHMSVIAGNIDM-UHFFFAOYSA-N benzoyl bromide Chemical compound BrC(=O)C1=CC=CC=C1 AQIHMSVIAGNIDM-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- DFFDSQBEGQFJJU-UHFFFAOYSA-N butyl hydrogen carbonate Chemical compound CCCCOC(O)=O DFFDSQBEGQFJJU-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001731 carboxylic acid azides Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000003678 cyclohexadienyl group Chemical group C1(=CC=CCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- YKGMKSIHIVVYKY-UHFFFAOYSA-N dabrafenib mesylate Chemical compound CS(O)(=O)=O.S1C(C(C)(C)C)=NC(C=2C(=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C=CC=2)F)=C1C1=CC=NC(N)=N1 YKGMKSIHIVVYKY-UHFFFAOYSA-N 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- WCQOBLXWLRDEQA-UHFFFAOYSA-N ethanimidamide;hydrochloride Chemical compound Cl.CC(N)=N WCQOBLXWLRDEQA-UHFFFAOYSA-N 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- KSRHWBLHVZJTKV-UHFFFAOYSA-N iodobenzene dichloride Chemical compound ClI(Cl)C1=CC=CC=C1 KSRHWBLHVZJTKV-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical group COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-N methyl hydrogen carbonate Chemical compound COC(O)=O CXHHBNMLPJOKQD-UHFFFAOYSA-N 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- RMHJJUOPOWPRBP-UHFFFAOYSA-N naphthalene-1-carboxamide Chemical group C1=CC=C2C(C(=O)N)=CC=CC2=C1 RMHJJUOPOWPRBP-UHFFFAOYSA-N 0.000 description 1
- 125000004998 naphthylethyl group Chemical group C1(=CC=CC2=CC=CC=C12)CC* 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 125000005244 neohexyl group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical group C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 125000005544 phthalimido group Chemical group 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- SOEVVANXSDKPIY-UHFFFAOYSA-M sodium glyoxylate Chemical compound [Na+].[O-]C(=O)C=O SOEVVANXSDKPIY-UHFFFAOYSA-M 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- CLURAKRVQIPBCC-UHFFFAOYSA-M sodium;perbromate Chemical compound [Na+].[O-]Br(=O)(=O)=O CLURAKRVQIPBCC-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Landscapes
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明は、セファロスポリン化合物,ペニシリン化合物
及びアゼチジノン化合物のアミノ基のアシル化の原料と
して有用な2−(5−アミノ−1,2,4−チアジアゾール
−3−イル)−2(Z)−ヒドロキシイミノ酢酸誘導
体、即ち一般式 [式中、R2は水素原子または置換されていてもよい炭化
水素基を示す]で表わされる化合物またはその塩の製造
方法に関する。TECHNICAL FIELD The present invention relates to 2- (5-amino-1,2,4-, which is useful as a raw material for acylation of amino groups of cephalosporin compounds, penicillin compounds and azetidinone compounds. Thiadiazol-3-yl) -2 (Z) -hydroxyiminoacetic acid derivative, ie, general formula [Wherein R 2 represents a hydrogen atom or an optionally substituted hydrocarbon group], or a salt thereof.
従来技術 一般式(I)で表わされるアミノチアジアゾール酢酸誘
導体の製造法としては、例えばマロン酸ジメチルから約
9工程を経て2−(5−アミノ−1,2,4−チアジアゾー
ル−3−イル)−2−エトキシイミノ酢酸を得る方法
(特開昭56−633988に記載)やアセトアミジン塩酸塩か
ら約6工程を経て2−(5−保護されたアミノ−1,2,4
−チアジアゾール−3−イル)−2−アルコキシイミノ
酢酸を製造する方法(特開昭53−53691,特開昭54−1064
91,特開昭55−11600,特開昭55−105689等に記載)等が
知られている。As a method for producing an aminothiadiazoleacetic acid derivative represented by the general formula (I), for example, 2- (5-amino-1,2,4-thiadiazol-3-yl)-is obtained from dimethyl malonate through about 9 steps. A method for obtaining 2-ethoxyiminoacetic acid (described in JP-A-56-633988) or 2- (5-protected amino-1,2,4) from acetamidine hydrochloride through about 6 steps
-Thiadiazol-3-yl) -2-alkoxyiminoacetic acid (JP-A-53-53691, JP-A-54-1064)
91, JP-A-55-11600, JP-A-55-105689, etc.) are known.
発明が解決しようとする問題点 これらの従来技術は、原料からアミノチアジアゾール酢
酸誘導体への製造工程が長く、しかも最初の原料からの
収率が10%以下と極めて低く、得られた化合物(I)の
純度も悪い。又工業的生産には利用し得ないような特殊
な試薬(例えば、ジイソプロピルアミノリチウム,ゼレ
ンオキサイド等)が必要であり到底工業的大量生産に適
した方法とはいえない。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention In these conventional techniques, the process for producing an aminothiadiazoleacetic acid derivative from a raw material is long, and the yield from the initial raw material is 10% or less, which is extremely low. Is also poor in purity. Further, a special reagent that cannot be used for industrial production (for example, diisopropylaminolithium, zelenium oxide, etc.) is required, and it cannot be said to be a method suitable for industrial mass production.
問題点を解決するための手段 本発明者等は、工業的により容易に目的化合物(I)ま
たはその塩を製造する方法につき研究を続けていたとこ
ろ、高収率でしかも高純度の目的化合物(I)またはそ
の塩を製造する方法を見い出し、さらに種々検討した結
果、本発明を完成した。Means for Solving the Problems The inventors of the present invention have been conducting research on a method for industrially and easily producing the target compound (I) or a salt thereof, and found that the target compound of high yield and high purity ( The present invention has been completed as a result of discovering a method for producing I) or a salt thereof and further conducting various studies.
即ち、本発明は、 一般式 [式中、環Aは置換されていてもよいベンゼン環を示
す]で表わされる化合物またはその塩を塩基の存在下に
加水分解し、ついでアシル化反応または/および中和反
応に付し、得られる一般式 [式中、環Aは前記と同意義、R1は水素原子またはアシ
ル基を示す]で表わされる化合物を酸化反応に付し、得
られる式 で表わされる化合物またはその塩と一般式 R2ONH2 (II) [式中、R2は水素原子または置換されていてもよい炭化
水素基を示す]で表わされる化合物またはその塩とを反
応させることを特徴とする一般式 [式中の記号は前記と同意義]で表わされる化合物また
はその塩の製造方法に関する。That is, the present invention has the general formula [Wherein ring A represents an optionally substituted benzene ring] or a salt thereof is hydrolyzed in the presence of a base, and then subjected to an acylation reaction and / or a neutralization reaction to obtain General formula [Wherein, ring A has the same meaning as defined above, R 1 represents a hydrogen atom or an acyl group], and the compound is obtained by subjecting it to an oxidation reaction. And a salt thereof represented by the general formula R 2 ONH 2 (II) [wherein R 2 represents a hydrogen atom or an optionally substituted hydrocarbon group] or a salt thereof is reacted. General formula characterized by The present invention relates to a method for producing a compound represented by the formula [wherein the symbols are as defined above] or a salt thereof.
本発明方法は、製造工程が短く、目的化合物(I)が原
料の化合物(V)から好収率かつ高純度で製造される。
しかも入手容易で安価な原料や試薬を用いるので工業的
生産に適した方法である。In the method of the present invention, the production process is short, and the target compound (I) is produced from the starting compound (V) in good yield and high purity.
Moreover, it is a method suitable for industrial production because it uses readily available and inexpensive raw materials and reagents.
さらに本方法においては原料化合物(V),(IV),
(III)のチアジアゾール環上のアミノ基は保護する必
要はなく、従来の公知反応のようにアミノ基の保護化反
応及び脱保護化反応が全く必要でなく、工程数も短縮さ
れるので極めて有利な方法である。Furthermore, in this method, the starting compounds (V), (IV),
The amino group on the thiadiazole ring of (III) does not need to be protected, and no amino group protection reaction or deprotection reaction is required unlike conventional known reactions, and the number of steps is shortened, which is extremely advantageous. That's the method.
本発明の出発物質(V)において環Aは、例えばハロゲ
ン原子,アルキル基,アルコキシ基,ヒドロキシル基,
ニトロ基,シアノ基、アシル基等から選ばれる1〜4の
置換基で置換されていてもよいベンゼン環を示す。ここ
においてハロゲン原子としては具体的には例えばフッ
素,塩素,臭素,ヨウ素等が用いられ、アルキル基とし
ては炭素数1から8の直鎖または分枝状のアルキル基で
具体的には例えばメチル,エチル,n−プロピル,i−プロ
ピル,n−ブチル,i−ブチル,sec−ブチル,t−ブチル,n−
ヘキシル,イソヘキシル,sec−ヘキシル,ネオヘキシ
ル,tert−ヘキシル,n−ヘプチル,イソヘプチル,sec−
ヘプチル,ネオヘプチル,tert−ヘプチル,n−オクチ
ル,イソオクチル,sec−オクチル,ネオオクチル,tert
−オクチル等、好ましくは炭素数1から4のアルキル基
で例えばメチル,エチル,n−プロピル,i−プロピル,n−
プロピル,i−ブチル,sec−ブチル,t−ブチル等が用いら
れ、アルコキシ基としては炭素数1から8の直鎖または
分枝状のアルコキシ基で具体的には例えばメトキシ,エ
トキシ,n−プロポキシ,イソプロポキシ,n−ブトキシ,
イソブトキシ,sec−ブトキシ,tert−ブトキシ,n−ペン
チルオキシ,イソペンチルオキシ,sec−ペンチルオキ
シ,ネオペンチルオキシ,tert−ペンチルオキシ,n−ヘ
キシルオキシ,イソヘキシルオキシ,sec−ヘキシルオキ
シ,ネオヘキシルオキシ,tert−ヘキシルオキシ,n−ヘ
プチルオキシ,イソヘプチルオキシ,sec−ヘプチルオキ
シ,ネオヘプチルオキシ,tert−ヘプチルオキシ,n−オ
クチルオキシ,イソオクチルオキシ,sec−オクチルオキ
シ,ネオオクチルオキシ,tert−オクチルオキシ等、好
ましくは炭素数1から4のアルコキシ基で例えばメトキ
シ,エトキシ,n−プロポキシ,イソプロポキシ,n−ブト
キシ,イソブトキシ,sec−ブトキシ,tert−ブトキシ等
が用いられ、アシル基としては、有機カルボン酸から誘
導されるアシル基で、例えば炭素数1から7のアルカイ
ル基(例、ホルミル,アセチル,プロピオニル,ブチリ
ン,イソブチリル,ペンタノイル,ヘキサノイル,ヘプ
タノイル等),炭素数6から14のアリール−カルボニル
基(例、ベンゾイル,ナフタレンカルボニル等),炭素
数1から4のアルコキシ−カルボニル基(例、メトキシ
カルボニル,エトキシカルボニル,プロポキシカルボニ
ル,イソプロポキシカルボニル,ブトキシカルボニル,
イソブトキシカルボニル,sec−ブトキシカルボニル,ter
t−ブトキシカルボニル等),炭素数6から14のアリー
ルオキシ−カルボニル基(例、フェノキシカルボニル
等),炭素数7から19のアラルキル−カルボニル基
(例、ベンジルカルボニル,フェネチルカルボニル,フ
ェニルプロピルカルボニル,ナフチルエチルカルボニル
等),5〜6員複素環カルボニル基(例、2−ピロリルカ
ルボニル,4−,2−または3−ピロリルカルボニル,3−,4
−または5−ピラゾリルカルボニル,2−,4−または5−
イミダゾリルカルボニル,1,2,3−または1,2,4−トリア
ゾリルカルボニル,1H−または2H−テトラゾリルカルボ
ニル,2−または3−フリルカルボニル,2−または3−チ
エニルカルボニル,2−,4−または5−オキサゾリルカル
ボニル,3−,4−または5−イソキサゾリルカルボニル,
1,2,3−オキサジアゾール−4−または5−イルカルボ
ニル,1,2,4−オキサジアゾール−3−または5−イルカ
ルボニル,1,2,5−または1,3,4−オキサジアゾールカル
ボニル,2−,4−または5−チアゾリルカルボニル,3−,4
−または5−イソチアゾリルカルボニル,1,2,3−チアジ
アゾール−4−または5−イルカルボニル,1,2,4−チア
ジアゾール−3−または5−イルカルボニル,1,2,5−ま
たは1,3,4−チアジアゾリルカルボニル,2−または3−
ピロリジニルカルボニル,2−,3−または4−ピリジルカ
ルボニル,2−,3−または4−ピリジル−N−オキシドカ
ルボニル,3−または4−ピリダジニルカルボニル,3−ま
たは4−ピリダジニル−N−オキシドカルボニル,2−,4
−または5−ピリミジニルカルボニル,2−,4−または5
−ピリミジニル−N−オキシドカルボニル,ピラジニル
カルボニル,2−,3−または4−ピペリジニルカルボニ
ル,ピペラジニルカルボニル,3H−インドール−2−ま
たは3−イルカルボニル,2−,3−または4−ピラニルカ
ルボニル,2−,3−または4−チオピラニルカルボニル,
ベンゾピラニルカルボニル,キノリルカルボニル,ピリ
ド[2,3−d]ピリミジニルカルボニル,1,5−,1,6−,1,
7,1,8−,2,6−または2,7−ナフチリジニルカルボニル,
チエノ[2,3−d]ピリジルカルボニル,ピリミドピリ
ジルカルボニル,ピラジノキノリルカルボニル,ベンゾ
ピラニルカルボニル等),5〜6員複素環アセチル基
(例、2−ピロリルアセチル,3−イミダゾリルアセチ
ル,5−イソオキサゾリルアセチル等),ハロゲノアルカ
ノイル基(炭素数1から7)(例、クロロアセチル,ジ
フルオロアセチル,トリフルオロアセチル,3−クロロプ
ロピオニル),置換された炭素数6から14のアリール−
カルボニル基(例、2,4−ジクロロベンゾイル,3,4−ジ
アセトキシベンゾイル,3,4−ジヒドロキシベンゾイル,
3,4−ジメトキシベンゾイル,4−ニトロベンゾイル,4−
メチルベンゾイル)等が用いられる。In the starting material (V) of the present invention, ring A is, for example, a halogen atom, an alkyl group, an alkoxy group, a hydroxyl group,
The benzene ring which may be substituted with 1 to 4 substituents selected from nitro group, cyano group, acyl group and the like is shown. Here, as the halogen atom, for example, fluorine, chlorine, bromine, iodine and the like are used, and as the alkyl group, a linear or branched alkyl group having 1 to 8 carbon atoms, specifically, for example, methyl, Ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, t-butyl, n-
Hexyl, isohexyl, sec-hexyl, neohexyl, tert-hexyl, n-heptyl, isoheptyl, sec-
Heptyl, neoheptyl, tert-heptyl, n-octyl, isooctyl, sec-octyl, neooctyl, tert
-Octyl and the like, preferably an alkyl group having 1 to 4 carbon atoms such as methyl, ethyl, n-propyl, i-propyl, n-
Propyl, i-butyl, sec-butyl, t-butyl and the like are used, and the alkoxy group is a linear or branched alkoxy group having 1 to 8 carbon atoms, specifically, for example, methoxy, ethoxy, n-propoxy. , Isopropoxy, n-butoxy,
Isobutoxy, sec-butoxy, tert-butoxy, n-pentyloxy, isopentyloxy, sec-pentyloxy, neopentyloxy, tert-pentyloxy, n-hexyloxy, isohexyloxy, sec-hexyloxy, neohexyloxy , tert-hexyloxy, n-heptyloxy, isoheptyloxy, sec-heptyloxy, neoheptyloxy, tert-heptyloxy, n-octyloxy, isooctyloxy, sec-octyloxy, neooctyloxy, tert-octyl Oxy or the like, preferably an alkoxy group having 1 to 4 carbon atoms such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy is used, and the acyl group is an organic group. An acyl group derived from a carboxylic acid, for example, an alkyl group having 1 to 7 carbon atoms. Yl group (eg, formyl, acetyl, propionyl, butyrin, isobutyryl, pentanoyl, hexanoyl, heptanoyl, etc.), aryl-carbonyl group having 6 to 14 carbon atoms (eg, benzoyl, naphthalenecarbonyl, etc.), alkoxy having 1 to 4 carbon atoms -Carbonyl group (eg, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl,
Isobutoxycarbonyl, sec-butoxycarbonyl, ter
t-butoxycarbonyl, etc.), an aryloxy-carbonyl group having 6 to 14 carbon atoms (eg, phenoxycarbonyl, etc.), an aralkyl-carbonyl group having 7 to 19 carbon atoms (eg, benzylcarbonyl, phenethylcarbonyl, phenylpropylcarbonyl, naphthyl) Ethylcarbonyl, etc.), 5- to 6-membered heterocyclic carbonyl group (eg, 2-pyrrolylcarbonyl, 4-, 2- or 3-pyrrolylcarbonyl, 3-, 4
-Or 5-pyrazolylcarbonyl, 2-, 4- or 5-
Imidazolylcarbonyl, 1,2,3- or 1,2,4-triazolylcarbonyl, 1H- or 2H-tetrazolylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2-, 4- or 5-oxazolylcarbonyl, 3-, 4- or 5-isoxazolylcarbonyl,
1,2,3-oxadiazol-4- or 5-ylcarbonyl, 1,2,4-oxadiazol-3- or 5-ylcarbonyl, 1,2,5- or 1,3,4-oxa Diazole carbonyl, 2-, 4- or 5-thiazolyl carbonyl, 3-, 4
-Or 5-isothiazolylcarbonyl, 1,2,3-thiadiazol-4- or 5-ylcarbonyl, 1,2,4-thiadiazol-3- or 5-ylcarbonyl, 1,2,5-or 1, 3,4-thiadiazolylcarbonyl, 2- or 3-
Pyrrolidinylcarbonyl, 2-, 3- or 4-pyridylcarbonyl, 2-, 3- or 4-pyridyl-N-oxidecarbonyl, 3- or 4-pyridazinylcarbonyl, 3- or 4-pyridazinyl-N -Oxidecarbonyl, 2-, 4
-Or 5-pyrimidinylcarbonyl, 2-, 4- or 5
-Pyrimidinyl-N-oxidecarbonyl, pyrazinylcarbonyl, 2-, 3- or 4-piperidinylcarbonyl, piperazinylcarbonyl, 3H-indol-2- or 3-ylcarbonyl, 2-, 3- or 4 -Pyranylcarbonyl, 2-, 3- or 4-thiopyranylcarbonyl,
Benzopyranylcarbonyl, quinolylcarbonyl, pyrido [2,3-d] pyrimidinylcarbonyl, 1,5-, 1,6-, 1,
7,1,8-, 2,6- or 2,7-naphthyridinylcarbonyl,
Thieno [2,3-d] pyridylcarbonyl, pyrimidopyridylcarbonyl, pyrazinoquinolylcarbonyl, benzopyranylcarbonyl, etc., 5- to 6-membered heterocyclic acetyl group (eg, 2-pyrrolylacetyl, 3-imidazolylacetyl) , 5-isoxazolylacetyl, etc.), halogenoalkanoyl groups (C1 to C7) (eg, chloroacetyl, difluoroacetyl, trifluoroacetyl, 3-chloropropionyl), substituted aryl having 6 to 14 carbons −
Carbonyl group (eg, 2,4-dichlorobenzoyl, 3,4-diacetoxybenzoyl, 3,4-dihydroxybenzoyl,
3,4-dimethoxybenzoyl, 4-nitrobenzoyl, 4-
Methylbenzoyl) and the like are used.
つぎに、本発明方法を順を追って説明する。Next, the method of the present invention will be described step by step.
化合物(IV)は化合物(V)またはその塩を塩基の存在
下に加水分解し、ついでアシル化反応または/および中
和反応に付すことにより製造することができる。Compound (IV) can be produced by hydrolyzing compound (V) or a salt thereof in the presence of a base, and then subjecting it to an acylation reaction and / or a neutralization reaction.
化合物(IV)中のR1で示されるアシル基としては化合物
(V)の環Aの置換分のアシル基と同様のものが用いら
れる。化合物(V)の塩としては、塩酸,硫酸,リン酸
等の無機酸、例えば酢酸,ベンゼンスルホン酸,p−トル
エンスルホン酸,メタンスルホン酸,クエン酸,酒石
酸,シユウ酸,プロピオン酸,マレイン酸,リンゴ酸,
マロン酸,フマル酸,マンデル酸,アスコルビン酸等の
有機酸との酸付加塩が用いられる。As the acyl group represented by R 1 in the compound (IV), the same acyl group as the substituent of the ring A of the compound (V) can be used. Examples of the salt of compound (V) include inorganic acids such as hydrochloric acid, sulfuric acid and phosphoric acid, such as acetic acid, benzenesulfonic acid, p-toluenesulfonic acid, methanesulfonic acid, citric acid, tartaric acid, oxalic acid, propionic acid and maleic acid. , Malic acid,
Acid addition salts with organic acids such as malonic acid, fumaric acid, mandelic acid and ascorbic acid are used.
本反応は化合物(V)またはその塩を塩基の存在下に加
水分解し、ついでアシル化反応には付すか、あるいは
中和反応に付すか、あるいはアシル化反応及び中和
反応に付す方法のいずれかの方法によって行なわれる。In this reaction, compound (V) or a salt thereof is hydrolyzed in the presence of a base and then subjected to an acylation reaction, a neutralization reaction, or an acylation reaction and a neutralization reaction. It is done by either method.
加水分解反応は、塩基の存在下に行なわれる。The hydrolysis reaction is carried out in the presence of a base.
適当な塩基としては、水酸化ナトリウム,水酸化カリウ
ム,水酸化リチウム等の水酸化アルカリ金属,炭酸ナト
リウム,炭酸カリウム等の炭酸アルカリ金属等が用いら
れる。Suitable bases include alkali metal hydroxides such as sodium hydroxide, potassium hydroxide and lithium hydroxide, and alkali metal carbonates such as sodium carbonate and potassium carbonate.
塩基は化合物(V)またはその塩に対して通常約2から
10倍モル量,好ましくは約2から5倍モル量用いられる
が、大過剰用いても差しつかえない。本加水分解反応
は、水単独または水と下記に示す親水性溶媒との混合溶
媒中で行なわれる。親水性溶媒としては、例えばメタノ
ール,エタノール等のアルコール類、ジオキサン,テト
ラヒドロフラン等のエーテル類、アセトン等のケトン
類、アセトニトリル等のニトリル類、ジメチルホルムア
ミド,ジメチルアセトアミド等のアミド類、ジメチルス
ルホキシド等のスルホキシド類が用いられる。The base is usually about 2 to the compound (V) or a salt thereof.
It is used in a 10-fold molar amount, preferably about a 2- to 5-fold molar amount, but a large excess can be used. This hydrolysis reaction is carried out in water alone or in a mixed solvent of water and a hydrophilic solvent shown below. Examples of the hydrophilic solvent include alcohols such as methanol and ethanol, ethers such as dioxane and tetrahydrofuran, ketones such as acetone, nitriles such as acetonitrile, amides such as dimethylformamide and dimethylacetamide, and sulfoxides such as dimethyl sulfoxide. Kinds are used.
水と親水性溶媒は適宜の割合で混合して用いてもよい。Water and the hydrophilic solvent may be mixed and used at an appropriate ratio.
本反応に於て、水は化合物(V)またはその塩に対して
少なくとも当モル量必要であるが、大過剰用いるのが好
ましい。In this reaction, water is required in at least an equimolar amount with respect to compound (V) or a salt thereof, but a large excess is preferably used.
反応温度は15から100℃程度好ましくは20から60℃程度
である。反応時間は10分から3時間程度で十分である。The reaction temperature is about 15 to 100 ° C, preferably about 20 to 60 ° C. A reaction time of 10 minutes to 3 hours is sufficient.
このようにして得られる化合物は一般式 [式中環Aは前記と同意義を、Mはアルカリ金属を示
す]で表わされることもできる。Mで表わされるアルカ
リ金属としては、リチウム,ナトリウム,カリウム等が
用いられる。The compound thus obtained has the general formula [Wherein ring A has the same meaning as described above, and M represents an alkali metal]. As the alkali metal represented by M, lithium, sodium, potassium and the like are used.
化合物(IV′)は、反応溶液のまゝ次反応に供してもよ
く、又自体公知の単離精製手段、例えば濃縮,減圧濃
縮,液性変換,転溶,溶媒抽出,結晶化,再結晶,クロ
マトグラフィー等により単離精製し、次反応の原料とし
て用いてもよい。The compound (IV ′) may be subjected to the subsequent reaction of the reaction solution, or may be isolated and purified by known means such as concentration, concentration under reduced pressure, liquid conversion, phase transfer, solvent extraction, crystallization, recrystallization. It may be isolated and purified by chromatography, etc. and used as a starting material for the next reaction.
(アシル化反応) アシル化反応は、化合物(V)又はその塩を塩基の存在
下に加水分解して得られる化合物[例えば化合物(I
V′)]とアシル化剤とを反応させることにより行なわ
れる。この反応において使用されるアシル化剤はR1で示
されるアシル基を含む有機カルボン酸[即ち一般式R1′
OH(式中R1′はアシル基を示す)で表わされる化合物]
もしくはその反応性誘導体であってもよい。(Acylation Reaction) The acylation reaction is a compound obtained by hydrolyzing the compound (V) or a salt thereof in the presence of a base [eg compound (I
V ')] is reacted with an acylating agent. The acylating agent used in this reaction organic carboxylic acids containing the acyl group represented by R 1 [i.e. formula R 1 '
Compounds represented by OH (wherein R 1 ′ represents an acyl group)]
Alternatively, it may be a reactive derivative thereof.
上記有機カルボン酸R1′OHの反応性誘導体としては、例
えば、カルボン酸ハライド,カルボン酸無水物,カルボ
ン酸の活性アミド,カルボン酸の活性エステル,カルボ
ン酸アジド,カルボン酸の活性チオエステル等が用いら
れ、このようなカルボン酸の反応性誘導体を具体的に述
べると次のとおりである。As the reactive derivative of the organic carboxylic acid R 1 ′ OH, for example, carboxylic acid halide, carboxylic acid anhydride, active amide of carboxylic acid, active ester of carboxylic acid, carboxylic acid azide, active thioester of carboxylic acid and the like are used. The reactive derivative of such a carboxylic acid is specifically described as follows.
(1)カルボン酸ハライド: 例えば、脂肪族カルボン酸ハライド(例、アセチルクロ
ライド,アセチルブロマイド),芳香族カルボン酸ハラ
イド(例、ベンゾイルクロライド,ベンゾイルブロマイ
ド)等が用いられる。(1) Carboxylic acid halide: For example, an aliphatic carboxylic acid halide (eg, acetyl chloride, acetyl bromide), an aromatic carboxylic acid halide (eg, benzoyl chloride, benzoyl bromide) or the like is used.
(2)カルボン酸無水物: 例えば、脂肪族カルボン酸無水物(例、無水酢酸),芳
香族カルボン酸無水物(例、無水安息香酸),モノ(炭
素数1から6)アルキル炭酸(例、モノメチル炭酸,モ
ノエチル炭酸,モノブチル炭酸)混合酸無水物,炭素数
1から6の脂肪族カルボン酸(例、ギ酸,酢酸,ピバル
酸,吉草酸,イソペンタン酸,トリクロル酢酸)混合酸
無水物(例、アセティックホルミックアンハイドライ
ド),芳香族カルボン酸(例、安息香酸,p−トルイル
酸,p−クロロ安息香酸)混合酸無水物等が用いられる。(2) Carboxylic acid anhydride: For example, aliphatic carboxylic acid anhydride (eg, acetic anhydride), aromatic carboxylic acid anhydride (eg, benzoic anhydride), mono (C 1 to C 6) alkyl carbonic acid (eg, Monomethyl carbonate, monoethyl carbonate, monobutyl carbonate) mixed acid anhydride, aliphatic carboxylic acid having 1 to 6 carbon atoms (eg, formic acid, acetic acid, pivalic acid, valeric acid, isopentanoic acid, trichloroacetic acid) mixed acid anhydride (eg, Acetic formic anhydride), aromatic carboxylic acid (eg, benzoic acid, p-toluic acid, p-chlorobenzoic acid) mixed acid anhydride and the like are used.
(3)カルボン酸の活性アミド: 例えば、ピラゾール,イミダゾール,4−置換イミダゾー
ル,ジメチルピラゾールもしくはベンゾトリアゾール等
の含窒素複素環化合物との酸アミドが用いられる。(3) Active amide of carboxylic acid: For example, an acid amide with a nitrogen-containing heterocyclic compound such as pyrazole, imidazole, 4-substituted imidazole, dimethylpyrazole or benzotriazole is used.
(4)カルボン酸の活性エステル: 例えば、メトキシメチルエステル,プロパルギルエステ
ル,4−ニトロフェニルエステル,2,4−ジニトロフェニル
エステル,トリクロロフェニルエステル,ペンタクロロ
フェニルエステル,メシルフェニルエステル等のエステ
ルが用いられる。さらに1−ヒドロキシ−1H−2−ピリ
ドン,N−ヒドロキシスクシンイミド,1−ヒドロキシベン
ツトリアゾール,N−ヒドロキシ−5−ノルボルネン−2,
3−ジカルボキシイミド,N−ヒドロキシフタルイミド等
と前記カルボン酸即ち一般式、 R1′OHで表わされる化合物とのエステル等が用いられ
る。(4) Active ester of carboxylic acid: For example, esters such as methoxymethyl ester, propargyl ester, 4-nitrophenyl ester, 2,4-dinitrophenyl ester, trichlorophenyl ester, pentachlorophenyl ester and mesylphenyl ester are used. Further, 1-hydroxy-1H-2-pyridone, N-hydroxysuccinimide, 1-hydroxybenztriazole, N-hydroxy-5-norbornene-2,
Esters and the like of 3-dicarboximide, N-hydroxyphthalimide and the like and the above-mentioned carboxylic acid, that is, the compound represented by the general formula, R 1 ′ OH, are used.
(5)カルボン酸の活性チオエステル: 例えば、芳香族複素環チオール化合物(たとえば2−ピ
リジルチオール,2−ベンゾチアゾリルチオール)とのエ
ステルなどが用いられる。(5) Active thioester of carboxylic acid: For example, an ester with an aromatic heterocyclic thiol compound (for example, 2-pyridylthiol, 2-benzothiazolylthiol) or the like is used.
上記(3)〜(5)で示した複素環化合物の複素環は前
記の炭素数1から8のアルキル基,炭素数1から8のア
ルコキシ基,ハロゲン原子や炭素数1から8のアルキル
チオ基(例、メチルチオ,エチルチオ,n−プロピルチ
オ,イソプロピルチオ,n−ブチルチオ,オクチルチオ)
などで置換されていてもよい。The heterocycle of the heterocyclic compound represented by the above (3) to (5) is an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a halogen atom or an alkylthio group having 1 to 8 carbon atoms ( (Eg, methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, octylthio)
It may be replaced with.
アシル化剤は化合物(V)またはその塩に対し約0.8か
ら5倍モル量、好ましくは約1から2倍モル量用いる。The acylating agent is used in an amount of about 0.8 to 5 times, preferably about 1 to 2 times the molar amount of the compound (V) or a salt thereof.
本反応は反応を阻害しない溶媒中で行なわれる。適当な
溶媒としては、加水分解反応に用いた溶媒をそのまゝ用
いてもよく、例えば水、メタノール,エタノール,n−プ
ロパノール,イソプロパノール等のアルコール類、ジオ
キサン,テトラヒドロフラン等のエーテル類、アセトン
等のケトン類、アセトニトリル等のニトリル類、ジメチ
ルホルムアミド,ジメチルアセトアミド等のアミド類等
の反応に不活性な溶媒が用いられる。これらの溶媒は必
要に応じ1種あるいは2種以上任意の割合で混合して用
いてもよい。このうち水,水とエタノールの混合溶媒、
水とジメチルホルムアミドの混合溶媒が好ましい。This reaction is carried out in a solvent that does not inhibit the reaction. As a suitable solvent, the solvent used for the hydrolysis reaction may be used as it is, and for example, water, alcohols such as methanol, ethanol, n-propanol and isopropanol, ethers such as dioxane and tetrahydrofuran, acetone and the like. A solvent inert to the reaction such as ketones, nitriles such as acetonitrile, and amides such as dimethylformamide and dimethylacetamide is used. These solvents may be used alone or as a mixture of two or more kinds at an arbitrary ratio, if necessary. Of these, water, a mixed solvent of water and ethanol,
A mixed solvent of water and dimethylformamide is preferable.
反応を円滑に進行させるためにさらに塩基を加えてもよ
く、適当な塩基としては、例えば水酸化カリウム,水酸
化ナトリウム,水酸化リチウム等の水酸化アルカリ金
属,水酸化カリウム等の水酸化アルカリ土類金属、炭酸
カリウム,炭酸ナトリウム等の炭酸アルカリ金属、炭酸
水素カリウム,炭酸水素ナトリウム等の炭酸水素アルカ
リ金属、炭酸カルシウム等の炭酸アルカリ土類金属等の
無機塩基が用いられる。A base may be further added to promote the reaction smoothly. Suitable bases include, for example, alkali metal hydroxides such as potassium hydroxide, sodium hydroxide and lithium hydroxide, and alkaline earth hydroxides such as potassium hydroxide. Inorganic bases such as alkali metals such as group metals, potassium carbonate and sodium carbonate, alkali metals such as potassium hydrogencarbonate and sodium hydrogencarbonate, and alkaline earth metals such as calcium carbonate are used.
反応温度は特に限定されないが、通常約−10〜30℃で行
なうのが好ましい。反応時間は30分から3時間程度であ
る。Although the reaction temperature is not particularly limited, it is usually preferably carried out at about -10 to 30 ° C. The reaction time is about 30 minutes to 3 hours.
このようにして得られる化合物は反応溶液のまゝ次反応
に供してもよく又自体公知の単離精製手段、例えば濃
縮,減圧濃縮,減圧蒸留,液性変換,転溶,溶媒抽出,
結晶化,再結晶,クロマトグラフィー等により単離精製
し、次反応に供してもよい。The compound thus obtained may be subjected to the subsequent reaction of the reaction solution, or may be isolated and purified by known methods such as concentration, concentration under reduced pressure, distillation under reduced pressure, liquid conversion, phase transfer, solvent extraction,
It may be isolated and purified by crystallization, recrystallization, chromatography, etc. and then used in the next reaction.
(中和反応) 本反応は常法に従って行なわれる。(Neutralization reaction) This reaction is carried out according to a conventional method.
中和反応は化合物(V)またはその塩を塩基の存在下に
加水分解もしくは加水分解後アシル化反応して得られる
アルカリ性の溶液に酸を加えることにより行なわれる。The neutralization reaction is carried out by hydrolyzing the compound (V) or a salt thereof in the presence of a base, or by adding an acid to an alkaline solution obtained by the hydrolysis followed by an acylation reaction.
ここにおいて、中和するための酸としては塩酸,硫酸,
リン酸等の無機酸が好適に用いられる。Here, as the acid for neutralization, hydrochloric acid, sulfuric acid,
An inorganic acid such as phosphoric acid is preferably used.
中和反応は、水単独または水と親水性溶媒との混合溶媒
中で行なわれる。親水性溶媒としては上記加水分解反応
で用いられたものと同様のものが用いられる。The neutralization reaction is carried out in water alone or in a mixed solvent of water and a hydrophilic solvent. The same hydrophilic solvent as that used in the above hydrolysis reaction is used.
本発明は発熱を伴う場合があるので冷却下に行なうのが
好ましい。通常反応液を0から10℃前後に保つのが適当
である。反応時間は15分から3時間程度である。Since the present invention may generate heat, it is preferably carried out under cooling. Usually, it is suitable to keep the reaction solution at about 0 to 10 ° C. The reaction time is about 15 minutes to 3 hours.
反応の終了はpHメーター,リトマス試験紙等で容易に確
認することができる。The end of the reaction can be easily confirmed with a pH meter, litmus test paper, etc.
中和反応によって反応生成物(化合物(IV))は通常固
体または結晶として析出する。析出物は常法に従って適
当な有機溶媒(後述の酸化反応を行なうのに適した溶媒
が好ましい。)に抽出,転溶して次反応に供してもよく
又所望により一旦単離精製してもよい。The reaction product (compound (IV)) is usually precipitated as a solid or crystal by the neutralization reaction. The precipitate may be extracted and transferred to a suitable organic solvent (preferably a solvent suitable for carrying out the oxidation reaction described below) according to a conventional method and then subjected to the next reaction, or if desired, once isolated and purified. Good.
化合物(III)またはその塩は化合物(IV)を酸化剤で
酸化することにより製造される。酸化剤としては、例え
ば過塩素酸ナトリウム,過塩素酸カリウム,過塩素酸カ
ルシウム,過臭素酸ナトリウム,過ヨウ素酸カリウム等
の過ハロゲン酸塩,過マンガン酸カリウム等の過マンガ
ン酸塩類,重クロム酸カリウム等の重クロム酸塩,オゾ
ン等が用いられる。このうち特にオゾンが好ましい。ま
た電解酸化も用いられる。Compound (III) or a salt thereof is produced by oxidizing compound (IV) with an oxidizing agent. Examples of the oxidizer include sodium perchlorate, potassium perchlorate, calcium perchlorate, sodium perbromate, perhalogenates such as potassium periodate, permanganates such as potassium permanganate, and dichromium. Dichromates such as potassium acid, ozone, etc. are used. Of these, ozone is particularly preferable. Electrolytic oxidation is also used.
酸化剤は化合物(III)を製造するに必要な量を適宜用
いればよく、理論的には原料の化合物(IV)1モル量に
対して、当モル量の活性な酸素を発生する量を用いれば
よく、通常約0.8から5倍モル量用いる。しかし大過剰
用いても差し支えはない。The oxidizing agent may be appropriately used in an amount necessary for producing the compound (III), and theoretically, an amount that generates an equimolar amount of active oxygen is used with respect to 1 molar amount of the compound (IV) as a raw material. The amount is usually 0.8 to 5 times the molar amount. However, there is no problem in using a large excess.
反応は一般に反応を阻害しない溶媒中で行なわれる。適
当な溶媒としては、反応に不活性な溶媒、例えば水,メ
タノール,エタノール,n−プロパノール,イソプロパノ
ール,n−ブタノール,tert−ブタノール等のアルコール
類、ジクロロメタン,クロロホルム,1,2−ジクロロエタ
ン,四塩化炭素,テトラクロルエタン等のハロゲン化炭
化水素類、アセトン,メチルエチルケトン等のケトン
類、アセトニトリル,プロピオニトリル等のニトリル
類、ジメチルホルムアミド,ジメチルアセトアミド等の
アミド類、酢酸メチル,酢酸エチル,酢酸ブチル等のエ
ステル類、等が用いられる。これらの溶媒は必要に応じ
1種あるいは2種以上任意の割合で混合して用いてもよ
い。The reaction is generally performed in a solvent that does not interfere with the reaction. Suitable solvents include solvents inert to the reaction, for example, water, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, tert-butanol, dichloromethane, chloroform, 1,2-dichloroethane, tetrachloride. Carbon, halogenated hydrocarbons such as tetrachloroethane, ketones such as acetone and methyl ethyl ketone, nitriles such as acetonitrile and propionitrile, amides such as dimethylformamide and dimethylacetamide, methyl acetate, ethyl acetate, butyl acetate, etc. And the like are used. These solvents may be used alone or as a mixture of two or more kinds at an arbitrary ratio, if necessary.
上記のうち好ましくはハロゲン化炭化水素類,エステル
類である。Of the above, halogenated hydrocarbons and esters are preferable.
反応温度は約−80から25℃の範囲で反応が進行する温度
を選びうるが、一般に約−70から0℃が適当である。反
応時間は反応基質の量,また例えばオゾン発生機の能力
により異なるが一般に5分ないし12時間程度である。The reaction temperature may be selected at a temperature at which the reaction proceeds in the range of about -80 to 25 ° C, but generally about -70 to 0 ° C is suitable. The reaction time varies depending on the amount of the reaction substrate and, for example, the capacity of the ozone generator, but is generally about 5 minutes to 12 hours.
反応の終了は薄層クロマトグラフィー,高速液体クロマ
トグラフィー等によって容易に確認することができる。The completion of the reaction can be easily confirmed by thin layer chromatography, high performance liquid chromatography and the like.
反応終了後、酸化剤としてオゾンを用いた場合反応液に
窒素ガスを導入して溶液中に残存するオゾンガスを除去
する。ついで反応液に酢酸ナトリウムや無機塩基(例え
ば水酸化カリウム,水酸化ナトリウム,水酸化リチウム
等の水酸化アルカリ金属、水酸化カルシウム等の水酸化
アルカリ土類金属、炭酸カリウム,炭酸ナトリウム等の
炭酸アルカリ金属、炭酸水素カリウム,炭酸水素ナトリ
ウム等の炭酸水素アルカリ金属、炭酸カルシウム等の炭
酸アルカリ土類金属等の無機塩基)等を加え常法により
化合物(III)を塩基との塩としてもよい。After the completion of the reaction, when ozone is used as the oxidant, nitrogen gas is introduced into the reaction solution to remove the ozone gas remaining in the solution. Then, the reaction solution is mixed with sodium acetate or an inorganic base (eg, alkali metal hydroxide such as potassium hydroxide, sodium hydroxide or lithium hydroxide, alkaline earth metal hydroxide such as calcium hydroxide, alkali carbonate such as potassium carbonate or sodium carbonate). The compound (III) may be converted into a salt with a base by adding a metal, an alkali metal hydrogencarbonate such as potassium hydrogencarbonate and sodium hydrogencarbonate, an inorganic base such as an alkaline earth metal carbonate such as calcium carbonate) and the like by a conventional method.
反応溶媒としてハロゲン化炭化水素類を用いた場合、反
応終了後は、反応液に水及び酢酸ナトリウムや炭酸ナト
リウム等を加えてアルカリ性にしたのち、化合物(II
I)の塩基との塩を水で抽出し、この抽出水溶液を次反
応に供してもよい。又反応溶媒として水,アルコール
類,ケトン類,ニトリル類,アミド類,エステル類を用
いた場合は、反応後一度溶媒を留去した後、水と酢酸ナ
トリウム(もしくは炭酸ナトリウム)及びハロゲン化炭
化水素類を加えよく混合した後二層分離して水層を分取
し、これを次反応の原料として用いてもよい。さらに化
合物(III)またはその塩は自体公知の単離精製手段、
例えば濃縮,減圧濃縮,液性変換,転溶,溶媒抽出,結
晶化,再結晶,クロマトグラフィー等により単離精製し
た後次反応に供してもよい。When a halogenated hydrocarbon is used as the reaction solvent, after completion of the reaction, water and sodium acetate, sodium carbonate or the like are added to the reaction solution to make it alkaline, and then the compound (II
The salt of I) with a base may be extracted with water, and this extracted aqueous solution may be subjected to the next reaction. When water, alcohols, ketones, nitriles, amides, and esters are used as reaction solvents, the solvent is distilled off after the reaction, and then water and sodium acetate (or sodium carbonate) and halogenated hydrocarbons are used. After adding the components and mixing well, the mixture may be separated into two layers and the aqueous layer may be separated and used as a raw material for the next reaction. Further, the compound (III) or a salt thereof can be isolated and purified by known means,
For example, it may be isolated and purified by concentration, concentration under reduced pressure, liquid conversion, phase transfer, solvent extraction, crystallization, recrystallization, chromatography, etc., and then subjected to the next reaction.
化合物(I)またはその塩は、化合物(III)またはそ
の塩を化合物(II)またはその塩とを反応させることに
より製造することができる。Compound (I) or a salt thereof can be produced by reacting compound (III) or a salt thereof with compound (II) or a salt thereof.
化合物(II)において、R2は水素原子または置換されて
いてもよい炭化水素基を示す。炭化水素基としては、例
えば、直鎖または分枝状の炭素数1から8のアルキル基
(以後、C1-8アルキル基と略すこともある),直鎖また
は分枝状の炭素数2から6のアルケニル基(以後、C2-6
アルケニル基と略すこともある),直鎖または分枝状の
炭素数2から6のアルキニル基(以後、C2-6アルキニル
基と略することもある),炭素数3から10のシクロアル
キル基(以後、C3-10シクロアルキル基と略すこともあ
る),炭素数5から6のシクロアルケニル基(以後、C
5-6シクロアルケニル基と略すこともある),炭素数6
から14のアリール基(以後、C6-14アリール基と略すこ
ともある),炭素数7から19のアラルキル基(以後、C
7-19アラルキル基と略すこともある)等が用いられる。
とりわけ、炭素数1から3の低級アルキル基(以後、C
1-3アルキル基と略すこともある)またはカルボキシル
基で置換されたC1-3アルキル基が好ましい。C1-8アルキ
ル基は化合物(V)における環Aの置換分で定義したも
のと同様のものが用いられる。In the compound (II), R 2 represents a hydrogen atom or an optionally substituted hydrocarbon group. Examples of the hydrocarbon group include a linear or branched alkyl group having 1 to 8 carbon atoms (hereinafter sometimes abbreviated as C 1-8 alkyl group), a linear or branched carbon atom having 2 carbon atoms. 6 alkenyl groups (hereinafter C 2-6
Alkenyl group), straight-chain or branched alkynyl group having 2 to 6 carbon atoms (hereinafter also abbreviated as C 2-6 alkynyl group), cycloalkyl group having 3 to 10 carbon atoms (Hereinafter sometimes abbreviated as C 3-10 cycloalkyl group), a cycloalkenyl group having 5 to 6 carbon atoms (hereinafter C
5-6 cycloalkenyl group), 6 carbon atoms
To 14 aryl groups (hereinafter sometimes abbreviated as C 6-14 aryl groups), C 7 to C 19 aralkyl groups (hereinafter C
7-19 aralkyl group may be abbreviated) etc. are used.
Particularly, a lower alkyl group having 1 to 3 carbon atoms (hereinafter, C
(Although abbreviated as 1-3 alkyl group) or a C 1-3 alkyl group substituted with a carboxyl group is preferable. As the C 1-8 alkyl group, the same one as defined for the substituent of ring A in compound (V) is used.
C2-6アルケニル基してはビニル,アリル,イソプロペニ
ル,メタリル,1,1−ジメチルアリル,2−ブテニル,3−ブ
テニルなどが用いられる。C2-6アルキニル基としてはエ
チニル,1−プロピニル,2−プロピニル(プロパルギル)
などが用いられる。C3-10シクロアルキル基としてはシ
クロプロピル,シクロブチル,シクロペンチル,シクロ
ヘキシル,シクロヘプチル,アダマンチルなどが用いら
れる。C5-6シクロアルケニル基としては2−シクロペン
テニル,3−シクロペンテニル,2−シクロヘキセニル,3−
シクロヘキセニル,シクロペンタジエニル,シクロヘキ
サジエニルなどが用いられる。C6-14アリール基しては
フェニル,ビフェニリル,ナフチル,アンスリルなどが
用いられる。C7-19のアラルキル基としてはベンジル,
フェネチル,フェニルプロピル,ナフチルメチル,ナフ
チルエチル,アンスリルメチルなどが用いられる。これ
らの炭化水素基の置換基としては例えば水酸基,C1-8ア
ルキル基,C2-6アルケニル基,C2-6アルキニル基,C
3-10シクロアルキル基,C5-6シクロアルケニル基,C
6-14アリール基,C7-19アラルキル基,複素環基,炭素
数1から8のアルコキシ基(以下C1-8アルコキシ基と略
すこともある),C3-10シクロアルキルオキシ基,C6-14
アリールオキシ基,C7-19アラルキルオキシ基,複素環
オキシ基,メルカプト基,C1-8アルキルチオ基,C3-10
シクロアルキルチオ基,C6-14アリールチオ基,C7-19ア
ラルキルチオ基,複素環チオ基,アミノ基,モノC1-8ア
ルキルアミノ基,ジC1-8アルキルアミノ基,トリC1-8ア
ルキルアンモニウム基,C3-10シクロアルキルアミノ
基,C6-14アリールアミノ基,C7-19アラルキルアミノ
基,複素環アミノ基,環状アミノ基,アジド基,ニトロ
基,ハロゲン原子,シアノ基,保護されていてもよいカ
ルボキシル基,C1-8アルコキシ−カルボニル基,C6-14
アリールオキシ−カルボニル基,C7-19アラルキルオキ
シカルボニル基,カルバモイル基,カルバモイルオキシ
基,フタルイミド基,炭素数1から7のアルカノイル
(以下C1-7アルカノイルと略すこともある)アミノ基,
C6-14アリール−カルボニルアミノ基,C1-8アルコキシ
−カルボキサミド基,C7-19アラルキルオキシ−カルボ
キサミド基などが用いられ、同一または異なって1〜3
個存在していてもよい。As the C 2-6 alkenyl group, vinyl, allyl, isopropenyl, methallyl, 1,1-dimethylallyl, 2-butenyl, 3-butenyl and the like are used. C 2-6 alkynyl groups include ethynyl, 1-propynyl, 2-propynyl (propargyl)
Are used. As the C 3-10 cycloalkyl group, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, adamantyl and the like are used. As the C 5-6 cycloalkenyl group, 2-cyclopentenyl, 3-cyclopentenyl, 2-cyclohexenyl, 3-
Cyclohexenyl, cyclopentadienyl, cyclohexadienyl and the like are used. Phenyl, biphenylyl, naphthyl, anthryl and the like are used as the C 6-14 aryl group. Benzyl as the aralkyl group for C 7-19 ,
Phenethyl, phenylpropyl, naphthylmethyl, naphthylethyl, anthrylmethyl and the like are used. Substituents for these hydrocarbon groups include, for example, hydroxyl group, C 1-8 alkyl group, C 2-6 alkenyl group, C 2-6 alkynyl group, C
3-10 cycloalkyl group, C 5-6 cycloalkenyl group, C
6-14 aryl group, C 7-19 aralkyl group, heterocyclic group, C 1-8 alkoxy group (hereinafter sometimes abbreviated as C 1-8 alkoxy group), C 3-10 cycloalkyloxy group, C 6-14
Aryloxy group, C 7-19 aralkyloxy group, heterocyclic oxy group, mercapto group, C 1-8 alkylthio group, C 3-10
Cycloalkylthio group, C 6-14 arylthio group, C 7-19 aralkylthio group, heterocyclic thio group, amino group, mono C 1-8 alkylamino group, di C 1-8 alkylamino group, tri C 1-8 Alkylammonium group, C 3-10 cycloalkylamino group, C 6-14 arylamino group, C 7-19 aralkylamino group, heterocyclic amino group, cyclic amino group, azido group, nitro group, halogen atom, cyano group, Optionally protected carboxyl group, C 1-8 alkoxy-carbonyl group, C 6-14
Aryloxy-carbonyl group, C 7-19 aralkyloxycarbonyl group, carbamoyl group, carbamoyloxy group, phthalimido group, alkanoyl having 1 to 7 carbon atoms (hereinafter sometimes abbreviated as C 1-7 alkanoyl) amino group,
A C 6-14 aryl-carbonylamino group, a C 1-8 alkoxy-carboxamide group, a C 7-19 aralkyloxy-carboxamide group or the like is used, and the same or different 1 to 3
Individuals may exist.
炭素水素基の置換基としては、C1-8アルキル基,C2-6ア
ルケニル基,C2-6アルキニル基,C3-10シクロアルキル
基,C5-6シクロアルケニル基,C6-14アリール基,C7-19
アラルキル基は前記のものが用いられ、C1-8アルコキシ
基は前記のもの、すなわちメトキシ,エトキシ,n−プロ
ポキシ,イソプロポキシ,n−ブトキシ,tert−ブトキシ,
n−ペンチルオキシ,n−ヘキシルオキシなどを、C3-10シ
クロアルキルオキシ基はシクロプロピルオキシ,シクロ
ヘキシルオキシなどを、C6-14アリールオキシ基はフェ
ノキシ,ナフチルオキシなどを、C7-19アラルキルオキ
シ基はベンジルオキシ,1−フェニルエチルオキシ,2−フ
ェニルエチルオキシ,ベンズヒドリルオキシなどを、C
1-8アルキルチオ基はメチルチオ,エチルチオ,n−プロ
ピルチオ,n−ブチルチオなどを、C3-10シクロアルキル
チオ基はシクロプロピルチオ,シクロヘキシルチオなど
を、C6-14アリールチオ基はフェニルチオ,ナフチルチ
オ,アンスリルチオなどを、C7-19アラルキルチオ基は
ベンジルチオ,フェニルエチルチオ,ベンズヒドリルチ
オなどを、モノC1-8アルキルアミノ基はメチルアミノ,
エチルアミノ,n−プロピルアミノ,n−ブチルアミノなど
を、ジC1-8アルキルアミノ基はジメチルアミノ,ジエチ
ルアミノ,メチルエチルアミノ,ジ−(n−プロピル)
アミノ,ジ−(n−ブチル)アミノなどを、トリC1-8ア
ルキルアンモニウム基はトリメチルアンモニウム,トリ
エチルアンモニウムなどを、C3-10シクロアルキルアミ
ノ基はシクロプロピルアミノ,シクロペンチルアミノ,
シクロヘキシルアミノなどを、C6-14アリールアミノ基
はアニリノ,N−メチルアニリノなどを、C7-19アラルキ
ルアミノ基はベンジルアミノ,1−フェニルエチルアミ
ノ,2−フェニルエチルアミノ,ベンズヒドリルアミノな
どを、環状アミノ基はピロリジノ,ピペリジノ,ピペラ
ジノ,モルホリノ,1−ピロリル,2−オキソ−3−ピロリ
ジニルなどを、ハロゲン原子はフッ素,塩素,臭素,ヨ
ウ素を、保護されたカルボキシル基としてはC1-8アルコ
キシ−カルボニル基(例えばメトキシカルボニル,エト
キシカルボニル,n−プロポキシカルボニル,イソプロポ
キシカルボニル,n−ブトキシカルボニル,イソブトキシ
カルボニル,tert−ブトキシカルボニル,シクロペンチ
ルオキシカルボニル,シクロヘキシルオキシカルボニル
など)を、C6-14アリールオキシ−カルボニル基(例え
ばフェノキシカルボニル,ナフチルオキシカルボニルな
ど)を、C7-19アラルキルオキシ−カルボニル基はベン
ジルオキシカルボニル,ベンズヒドリルオキシカルボニ
ルなどを、C1-6アルカノイルアミノ基はたとえばアセチ
ルアミノ,プロピオニルアミノ,ブチリルアミノ,バレ
リルアミノ,ピバロイルアミノなどを、C6-14アリール
−カルボニルアミノ基はたとえばベンズアミド,ナフト
イルアミド,フタルイミドなどを、C1-8アルコキシ−カ
ルボキサミド基はたとえばメトキシカルボキサミド(CH
3OCONH-),エトキシカルボキサミド,tert-ブトキシカ
ルボキサミドなどを、C7-19アラルキルオキシ‐カルボ
キサミド基はたとえばベンジルオキシカルボキサミド
(C6H5CH2OCONH-),ベンズヒドリルオキシカルボキサ
ミドなどを表わす。As the substituent of the carbon-hydrogen group, a C 1-8 alkyl group, a C 2-6 alkenyl group, a C 2-6 alkynyl group, a C 3-10 cycloalkyl group, a C 5-6 cycloalkenyl group, C 6-14 Aryl group, C 7-19
As the aralkyl group, those described above are used, and as the C 1-8 alkoxy group, those described above, that is, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, tert-butoxy,
n-pentyloxy, n-hexyloxy, etc., C 3-10 cycloalkyloxy groups such as cyclopropyloxy, cyclohexyloxy, etc., C 6-14 aryloxy groups such as phenoxy, naphthyloxy, etc., C 7-19 aralkyl Oxy groups include benzyloxy, 1-phenylethyloxy, 2-phenylethyloxy, benzhydryloxy, C
1-8 alkylthio groups include methylthio, ethylthio, n-propylthio, n-butylthio, etc., C 3-10 cycloalkylthio groups include cyclopropylthio, cyclohexylthio, etc., C 6-14 arylthio groups include phenylthio, naphthylthio, anthrylthio, etc. , C 7-19 aralkylthio group is benzylthio, phenylethylthio, benzhydrylthio, etc., mono C 1-8 alkylamino group is methylamino,
Ethylamino, n-propylamino, n-butylamino, etc., di C 1-8 alkylamino groups are dimethylamino, diethylamino, methylethylamino, di- (n-propyl)
Amino, di- (n-butyl) amino, etc., tri C 1-8 alkylammonium group is trimethylammonium, triethylammonium, etc., C 3-10 cycloalkylamino group is cyclopropylamino, cyclopentylamino,
Cyclohexylamino, etc., C 6-14 arylamino groups such as anilino, N-methylanilino, etc., C 7-19 aralkylamino groups such as benzylamino, 1-phenylethylamino, 2-phenylethylamino, benzhydrylamino, etc. , Cyclic amino groups are pyrrolidino, piperidino, piperazino, morpholino, 1-pyrrolyl, 2-oxo-3-pyrrolidinyl, halogen atoms are fluorine, chlorine, bromine and iodine, and protected carboxyl groups are C 1-8. An alkoxy-carbonyl group (eg, methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, tert-butoxycarbonyl, cyclopentyloxycarbonyl, cyclohexyloxycarbonyl, etc.) can be substituted with C 6-14 Aryloxy- Carbonyl group (e.g. phenoxycarbonyl, naphthyl etc. chill oxycarbonyl) a, C 7-19 aralkyloxy - carbonyl group benzyloxycarbonyl, benzhydryloxy carbonyl, etc., C 1-6 alkanoylamino groups such as acetylamino, propionylamino , Butyrylamino, valerylamino, pivaloylamino, etc., C 6-14 aryl-carbonylamino groups such as benzamide, naphthoylamide, phthalimide, etc., C 1-8 alkoxy-carboxamide groups such as methoxycarboxamide (CH
3 OCONH-), ethoxycarboxamide, tert-butoxycarboxamide and the like, and the C 7-19 aralkyloxy-carboxamide group represents, for example, benzyloxycarboxamide (C 6 H 5 CH 2 OCONH-), benzhydryloxycarboxamide and the like.
複素環基,複素環オキシ基,複素環チオ基および複素環
アミノ基の複素環基はたとえば窒素原子(オキシド化さ
れていてもよい),酸素原子,硫黄原子などのヘテロ原
子を1〜数個,好ましくは1〜4個含む5〜8員環基ま
たはその縮合環基をいう。このような複素環基としては
ぐたて的には2−または3−ピロリル,3−,4−または5
−ピラゾリル,2−,4−または5−イミダゾリル,1,2,3−
または1,2,4−トリアゾリル,1H−または2H−テトラゾリ
ル,2−または3−フリル,2−または3−チエニル,2−,4
−または5−オキサゾリル,3−,4−または5−イソキサ
ゾリル,1,2,3−オキサジアゾール−4−または5−イ
ル,1,2,4−オキサジアゾール−3−または5−イル,1,
2,5−または1,3,4−オキサジアゾリル,2−,4−または5
−チアゾリル,3−,4−または5−イソチアゾリル,1,2,3
−チアジアゾール−4−または5−イル,1,2,4−チアジ
アゾール−3−または5−イル,1,2,5−または1,3,4−
チアジアゾリル,2−または3−ピロリジニル,2−,3−ま
たは4−ピリジル,2−,3−または4−ピリジル−N−オ
キシド,3−または4−ピリダジニル,3−または4−ピリ
ダジニル−N−オキシド,2−,4−または5−ピリミジニ
ル,2−,4−または5−ピリミジニル−N−オキシド,ピ
ラジニル,2−,3−または4−ピペリジニル,ピペラジニ
ル,3H−インドール−2−または3−イル,2−,3−また
は4−ピラニル,2−,3−または4−チオピラニル,ベン
ゾピラニル,キノリル,ピリド[2,3−d]ピリミジニ
ル,1,5−,1,6−,1,7−,1,8−,2,6−または2,7−ナフチ
リジニル,チエノ[2,3−d]ピリジル,ピリミドピリ
ジル,ピラジノキノリル,ベンゾピラニルなどが用いら
れる。The heterocyclic group of the heterocyclic group, the heterocyclic oxy group, the heterocyclic thio group and the heterocyclic amino group has, for example, one to several heteroatoms such as nitrogen atom (which may be oxidized), oxygen atom and sulfur atom. , Preferably a 5- to 8-membered ring group containing 1 to 4 or a condensed ring group thereof. As such a heterocyclic group, 2- or 3-pyrrolyl, 3-, 4- or 5-
-Pyrazolyl, 2-, 4- or 5-imidazolyl, 1,2,3-
Or 1,2,4-triazolyl, 1H- or 2H-tetrazolyl, 2- or 3-furyl, 2- or 3-thienyl, 2-, 4
-Or 5-oxazolyl, 3-, 4- or 5-isoxazolyl, 1,2,3-oxadiazol-4- or 5-yl, 1,2,4-oxadiazol-3- or 5-yl, 1,
2,5- or 1,3,4-oxadiazolyl, 2-, 4- or 5
-Thiazolyl, 3-, 4- or 5-isothiazolyl, 1,2,3
-Thiadiazol-4- or 5-yl, 1,2,4-thiadiazol-3- or 5-yl, 1,2,5- or 1,3,4-
Thiadiazolyl, 2- or 3-pyrrolidinyl, 2-, 3- or 4-pyridyl, 2-, 3- or 4-pyridyl-N-oxide, 3- or 4-pyridazinyl, 3- or 4-pyridazinyl-N-oxide , 2-, 4- or 5-pyrimidinyl, 2-, 4- or 5-pyrimidinyl-N-oxide, pyrazinyl, 2-, 3- or 4-piperidinyl, piperazinyl, 3H-indol-2- or 3-yl, 2-, 3- or 4-pyranyl, 2-, 3- or 4-thiopyranyl, benzopyranyl, quinolyl, pyrido [2,3-d] pyrimidinyl, 1,5-, 1,6-, 1,7-, 1 , 8-, 2,6- or 2,7-naphthyridinyl, thieno [2,3-d] pyridyl, pyrimidopyridyl, pyrazinoquinolyl, benzopyranyl and the like are used.
置換された炭化水素基でより好ましいものは水酸基,C
3-10シクロアルキル基,C1-8アルコキシ基,C1-8アルキ
ルチオ基,アミノ基,トリC1-8アルキルアンモニウム
基,ハロゲン原子,カルボキシル基,C1-8アルコキシ‐
カルボニル基,カルバモイル基,シアノ基,アジド基,
複素環基などで1ないし3個置換されたC1-3アルキル基
(C1-3アルキル基はメチル,エチル,n−プロピル,イソ
プロピルなどをいう)であり、それらを具体的にあげる
と、シクロプロピルメチル,メトキシメチル,エトキシ
メチル,1−メトキシエチル,2−メトキシエチル,1−エト
キシエチル,2−ヒドロキシエチル,メチルチオメチル,2
−アミノエチル,2−(トリメチルアンモニウム)エチ
ル,2−(トリエチルアンモニウム)エチル,フルオロメ
チル,ジフルオロメチル,2−フルオロエチル,2,2−ジフ
ルオロエチル,クロロメチル,2−クロロエチル,2,2−ジ
クロロエチル,2,2,2−トリクロロエチル,2−ブロモエチ
ル,2−ヨードエチル,2,2,2−トリフルオロエチル,カル
ボキシメチル,1−カルボキシエチル,2−カルボキシエチ
ル,2−カルボキシプロピル,3−カルボキシプロピル,1−
カルボキシブチル,1−カルボキシベンジル,1−カルボキ
シ−4′−ヒドロキシベンジル,シアノメチル,1−カル
ボキシ−1−メチルエチル,メトキシカルボニルメチ
ル,エトキシカルボニルメチル,tert−ブトキシカルボ
ニルメチル,1−エトキシカルボニル−1−メチルエチ
ル,1−エトキシカルボニル−1−メチルエチル,1−tert
−ブトキシカルボニル−1−メチルエチル,1−ベンジル
オキシカルボニル−1−メチルエチル,1−ピバロイルオ
キシカルボニル−1−メチルエチル,カルバモイルメチ
ル,2−アジドエチル,2−(ピラゾリル)エチル,2−(イ
ミダゾリル)エチル,2−(2−オキソピロリジン−3−
イル)エチル,2−アミノ−4−チアゾリルメチル,4−イ
ミダゾリルメチル,2−オキソ−3−ピロリジニル,(5
−アミノ−1,2,4−チアジアゾリル−3−イル)メチル
などである。具体的にあげた炭化水素基のうち最も好ま
しいものはメチル,エチル,n−プロピルなどの直鎖状の
C1-3アルキル基および2−フルオロエチル,2−クロロエ
チル,2−ヒドロキシエチル,2−メトキシエチル,シアノ
メチル,カルボキシメチル,シクロプロピルメチル,ter
t−ブトキシカルボニルメチル,1−カルボキシ−1−メ
チルエチル,1−tert−ブトキシカルボニル−1−メチル
エチルなどのハロゲン原子,水酸基,C1-8アルコキシ
基,カルボキシル基,C1-8アルコキシ‐カルボニル基,
シアノ基で置換された直鎖又は分枝状のC1-3アルキル基
およびアリル基,プロパルギル基である。More preferred substituted hydrocarbon group is hydroxyl group, C
3-10 cycloalkyl group, C 1-8 alkoxy group, C 1-8 alkylthio group, amino group, tri-C 1-8 alkylammonium group, halogen atom, carboxyl group, C 1-8 alkoxy-
Carbonyl group, carbamoyl group, cyano group, azido group,
A C 1-3 alkyl group (C 1-3 alkyl group refers to methyl, ethyl, n-propyl, isopropyl, etc.) substituted with 1 to 3 heterocyclic groups and the like, and specific examples thereof include: Cyclopropylmethyl, methoxymethyl, ethoxymethyl, 1-methoxyethyl, 2-methoxyethyl, 1-ethoxyethyl, 2-hydroxyethyl, methylthiomethyl, 2
-Aminoethyl, 2- (trimethylammonium) ethyl, 2- (triethylammonium) ethyl, fluoromethyl, difluoromethyl, 2-fluoroethyl, 2,2-difluoroethyl, chloromethyl, 2-chloroethyl, 2,2-dichloro Ethyl, 2,2,2-trichloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2,2-trifluoroethyl, carboxymethyl, 1-carboxyethyl, 2-carboxyethyl, 2-carboxypropyl, 3-carboxy Propyl, 1-
Carboxybutyl, 1-carboxybenzyl, 1-carboxy-4'-hydroxybenzyl, cyanomethyl, 1-carboxy-1-methylethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, tert-butoxycarbonylmethyl, 1-ethoxycarbonyl-1- Methylethyl, 1-ethoxycarbonyl-1-methylethyl, 1-tert
-Butoxycarbonyl-1-methylethyl, 1-benzyloxycarbonyl-1-methylethyl, 1-pivaloyloxycarbonyl-1-methylethyl, carbamoylmethyl, 2-azidoethyl, 2- (pyrazolyl) ethyl, 2- ( Imidazolyl) ethyl, 2- (2-oxopyrrolidine-3-
Yl) ethyl, 2-amino-4-thiazolylmethyl, 4-imidazolylmethyl, 2-oxo-3-pyrrolidinyl, (5
-Amino-1,2,4-thiadiazolyl-3-yl) methyl and the like. The most preferable hydrocarbon group among the listed hydrocarbon groups is a linear chain such as methyl, ethyl or n-propyl.
C 1-3 alkyl group and 2-fluoroethyl, 2-chloroethyl, 2-hydroxyethyl, 2-methoxyethyl, cyanomethyl, carboxymethyl, cyclopropylmethyl, ter
halogen atom such as t-butoxycarbonylmethyl, 1-carboxy-1-methylethyl, 1-tert-butoxycarbonyl-1-methylethyl, hydroxyl group, C 1-8 alkoxy group, carboxyl group, C 1-8 alkoxy-carbonyl Basis,
A linear or branched C 1-3 alkyl group substituted with a cyano group, an allyl group, and a propargyl group.
化合物(II)の塩としては例えば塩酸,臭化水素酸,硫
酸,硝酸などの無機酸、例えばシュウ酸,トリフルオロ
酢酸,p−トルエンスルホン酸等の有機酸などの酸付加塩
が用いられる。As the salt of the compound (II), for example, an inorganic acid such as hydrochloric acid, hydrobromic acid, sulfuric acid or nitric acid, or an acid addition salt such as an organic acid such as oxalic acid, trifluoroacetic acid or p-toluenesulfonic acid is used.
化合物(II)においてR2で示される置換されていてもよ
い炭化水素基中に、アミノ基,置換アミノ基が存在する
場合これらの基は上記の無機酸や有機酸と酸付加塩を形
成していてもよく、又、カルボキシル基,スルホ基等が
存在する場合、例えばナトリウム,カリウム等のアルカ
リ金属、例えばカルシウム,マグネシウム等のアルカリ
土類金属、例えばトリエチルアミン,トリメチルアミ
ン,ピリジン,コリジン,ピコリン,ルチジン等の有機
アミン等の塩基との塩を形成していてもよい。When an amino group or a substituted amino group is present in the optionally substituted hydrocarbon group represented by R 2 in the compound (II), these groups form an acid addition salt with the above-mentioned inorganic acid or organic acid. When a carboxyl group, a sulfo group and the like are present, for example, an alkali metal such as sodium and potassium, an alkaline earth metal such as calcium and magnesium, such as triethylamine, trimethylamine, pyridine, collidine, picoline and lutidine. May form a salt with a base such as an organic amine.
化合物(III)は分子中にアミノ基を有しているので例
えば塩酸,硫酸,硝酸などの無機酸、例えばシュウ酸,
トリフルオロ酢酸,p−トルエンスルホン酸等の有機酸な
どの酸付加塩として用いてもよく、又分子中にカルボキ
シル基を有しているので例えばナトリウム,カリウム等
のアルカリ金属、例えばカルシウム,マグネシウム等の
アルカリ土類金属、例えばトリエチルアミン,トリメチ
ルアミン,ピリジン,コリジン,ルチジン等の有機アミ
ン等の塩基との塩として用いてもよい。Since the compound (III) has an amino group in the molecule, for example, an inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, such as oxalic acid,
It may be used as an acid addition salt of an organic acid such as trifluoroacetic acid or p-toluenesulfonic acid, and since it has a carboxyl group in the molecule, it is an alkali metal such as sodium or potassium, such as calcium or magnesium. Alkaline earth metal, for example, a salt with a base such as an organic amine such as triethylamine, trimethylamine, pyridine, collidine and lutidine may be used.
本反応において化合物(II)またはその塩は化合物(II
I)またはその塩に対して約0.8から5倍モル量好ましく
は約1から2倍モル量用いる。In this reaction, the compound (II) or its salt is
The molar amount is about 0.8 to 5 times, preferably about 1 to 2 times the molar amount of I) or a salt thereof.
本反応は反応を阻害しない溶媒中で行なわれる。適当な
溶媒としては、例えば水、メタノール,エタノール,n−
プロパノール,イソプロパノール,n−ブタノール,tert
−ブタノール等のアルコール類、ベンゼン,トルエン,
キシレン,ニトロベンゼン,クロルベンゼン等の芳香族
炭化水素類、ジクロロメタン,クロロホルム,テトラク
ロルエタン,四塩化炭素等のハロゲン化炭素水素類、エ
チルエーテル,ジオキサン,イソプロピルエーテル,テ
トラヒドロフラン等のエーテル類、アセトン,メチルエ
チルケトン等のケトン類、アセトニトリル,プロピオニ
トリル等のニトリル類、ジメチルホルムアミド,ジメチ
ルアセトアミド,ヘキサンメチル燐酸トリアミド等のア
ミド類、酢酸メチル,酢酸エチル,酢酸ブチル等のエス
テル類、ジメチルスルホキシド等のスルホキシド類、ギ
酸,酢酸,プロピオン酸等の脂肪族カルボン酸類、ピリ
ジン,γ−コリジン,キノリン,トリエチルアミン,ト
リ−n−プロピルアミン,N,N−ジメチルアニリン等の第
三級有機アミン類等が用いられる。これらの溶媒は必要
に応じ1種あるいは2種以上任意の割合で混合して用い
てもよい。このうち水,水とエタノールの混合溶媒、水
とジメチルホルムアミドの混合溶媒が好ましい。This reaction is carried out in a solvent that does not inhibit the reaction. Suitable solvents include, for example, water, methanol, ethanol, n-
Propanol, isopropanol, n-butanol, tert
-Alcohols such as butanol, benzene, toluene,
Aromatic hydrocarbons such as xylene, nitrobenzene, chlorobenzene, halogenated carbon hydrogens such as dichloromethane, chloroform, tetrachloroethane, carbon tetrachloride, ethers such as ethyl ether, dioxane, isopropyl ether, tetrahydrofuran, acetone, methyl ethyl ketone Such as ketones, nitriles such as acetonitrile and propionitrile, amides such as dimethylformamide, dimethylacetamide and hexanemethylphosphoric triamide, esters such as methyl acetate, ethyl acetate and butyl acetate, sulfoxides such as dimethyl sulfoxide, Aliphatic carboxylic acids such as formic acid, acetic acid, propionic acid, etc., tertiary organic amines such as pyridine, γ-collidine, quinoline, triethylamine, tri-n-propylamine, N, N-dimethylaniline, etc. Used. These solvents may be used alone or as a mixture of two or more kinds at an arbitrary ratio, if necessary. Of these, water, a mixed solvent of water and ethanol, and a mixed solvent of water and dimethylformamide are preferable.
本反応は反応を円滑に進行させるために塩基の存在下に
行なってもよい。適当な塩基としては、例えば水酸化カ
リウム,水酸化ナトリウム等の水酸化アルカリ金属、水
酸化カルシウム等の水酸化アルカリ土類金属、炭酸カリ
ウム,炭酸ナトリウム等の炭酸アルカリ金属、炭酸水素
カリウム,炭酸水素ナトリウム等の炭酸水素アルカリ金
属、炭酸カルシウム等の炭酸アルカリ土類金属等の無機
塩基が用いられる。This reaction may be carried out in the presence of a base to allow the reaction to proceed smoothly. Suitable bases include, for example, alkali metal hydroxides such as potassium hydroxide and sodium hydroxide, alkaline earth metal hydroxides such as calcium hydroxide, alkali metal carbonates such as potassium carbonate and sodium carbonate, potassium hydrogen carbonate and hydrogen carbonate. An inorganic base such as an alkali metal hydrogen carbonate such as sodium and an alkaline earth metal carbonate such as calcium carbonate is used.
この反応において、化合物(II)の酸付加塩を使用する
場合には、上記の塩基の存在下に反応を行なうのが好ま
しい。In this reaction, when the acid addition salt of compound (II) is used, it is preferable to carry out the reaction in the presence of the above base.
反応温度は特に限定されないが、通常約−20から30℃で
行なうのが好ましい。Although the reaction temperature is not particularly limited, it is usually preferably carried out at about -20 to 30 ° C.
化合物(I)の塩としては、分子中に、アミノ基が存在
するので、例えば塩酸,臭化水素酸,硫酸,リン酸,硝
酸等の無機酸、例えば酢酸,ベンゼンスルホン酸,トリ
フルオロ酢酸,p−トルエンスルホン酸,メタンスルホン
酸,クエン酸,酒石酸,シュウ酸,プロピオン酸,マレ
イン酸,リンゴ酸,マロン酸,フマル酸,マンデル酸,
アスコルビン酸等の有機酸との付加塩が用いられる。The salt of compound (I) has an amino group in the molecule, and therefore, for example, inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, nitric acid, such as acetic acid, benzenesulfonic acid, trifluoroacetic acid, p-toluenesulfonic acid, methanesulfonic acid, citric acid, tartaric acid, oxalic acid, propionic acid, maleic acid, malic acid, malonic acid, fumaric acid, mandelic acid,
An addition salt with an organic acid such as ascorbic acid is used.
又分子中にカルボキシル基を有しているので、例えばナ
トリウム,カリウム等のアルカリ金属、例えばカルシウ
ム,マグネシウム等のアルカリ土類金属、例えばトリエ
チルアミン,トリメチルアミン,ピリジン,コリジン,
ピコリン,ルチジン等の有機アミン等の塩基との塩が用
いられる。化合物(I)が遊離体で得られる場合は、自
体公知の方法に従って上記の酸付加塩や塩基との塩とす
ることができる。又化合物(I)が塩として得られる場
合は自体公知の方法に従って遊離体とすることができ
る。Further, since it has a carboxyl group in the molecule, for example, alkali metals such as sodium and potassium, alkaline earth metals such as calcium and magnesium, such as triethylamine, trimethylamine, pyridine, collidine,
A salt with a base such as an organic amine such as picoline or lutidine is used. When compound (I) is obtained as a free form, it can be converted into the above-mentioned acid addition salt or salt with a base according to a method known per se. When the compound (I) is obtained as a salt, it can be converted into a free form according to a method known per se.
このようにして得られる化合物(I)またはその塩は自
体公知の単離精製手段、例えば濃縮,減圧濃縮,減圧蒸
留,液性変換,転溶,溶媒抽出,結晶化,再結晶,クロ
マトグラフィー等により単離精製することができる。The thus-obtained compound (I) or a salt thereof is isolated and purified by a known method, for example, concentration, vacuum concentration, vacuum distillation, liquid conversion, phase transfer, solvent extraction, crystallization, recrystallization, chromatography and the like. It can be isolated and purified by.
本発明の目的化合物(I)またはその塩は抗菌作用やβ
−ラクタマーゼ阻害作用を有するアゼチジノン化合物,
セファロスポリン化合物,ペニシリン化合物(例、特開
昭53−53691,特開昭56−18988に記載のセファロスポリ
ン化合物)の原料として有用である。The object compound (I) of the present invention or a salt thereof has an antibacterial action or β
An azetidinone compound having a lactamase inhibitory action,
It is useful as a raw material for cephalosporin compounds and penicillin compounds (eg, cephalosporin compounds described in JP-A-53-53691 and JP-A-56-18988).
これらのアゼチジノン,ホファロスポリン及びペニシリ
ン化合物は、化合物(I)またはその塩を用いて自体公
知の方法(例えば特開昭57−156495;特開昭54−48790に
記載の方法)に従って製造される。例えば下記図式に示
される方法によりセファロスポリン化合物が製造され
る。These azetidinone, hofalosporin and penicillin compounds can be produced using compound (I) or a salt thereof according to a method known per se (for example, the method described in JP-A-57-156495; JP-A-54-48790). . For example, a cephalosporin compound is produced by the method shown in the following scheme.
上記式中、ZはS,S→O,OまたはCH2を、R3は水素原子,
メトキシ基またはホルムアミド基を、R4は水素原子,メ
チル基,水酸基またはハロゲン原子を、A は置換され
ていてもよい2,3−位または3,4−位で縮合環を形成する
イミダゾリウム−1−イル基を、それぞれ示す。ここで
R4で示されるハロゲン原子はフッ素,塩素,臭素,ヨウ
素をいう。置換分A において縮合環はイミダゾール環
と5〜6員芳香族複素環が縮合した形のものを意味し、
この縮合環はさらに別の芳香環または芳香族複素環と縮
合していてもよい。また置換基Aの右肩に付記したは
置換基Aが1価の陽電荷を持つことを示す。置換されて
いてもよい2,3−位または3,4−位で縮合環を形成するイ
ミダリウム−1−イル基(A )の例としては、上記し
た炭化水素基(R2)やアシル基(R1)で置換されていて
もよいイミダゾ[1,2−a]ピリジニウム−1−イル基 イミダゾ[1,2−b]ピリダジニウム−1−イル基 イミダゾ[1,5−a]ピリジニウム−2−イル基 があげられる。 In the above formula, Z is S, S → O, O or CH2, R3Is a hydrogen atom,
R is a methoxy group or a formamide group.FourIs a hydrogen atom,
A chill group, hydroxyl group or halogen atom Is replaced
Optionally form a condensed ring at the 2,3-position or 3,4-position
The imidazolium-1-yl groups are shown respectively. here
RFourThe halogen atom represented by is fluorine, chlorine, bromine, or iodine.
Say elementary. Substitution A The fused ring is an imidazole ring
And a 5- to 6-membered aromatic heterocycle are condensed,
This fused ring is condensed with another aromatic ring or aromatic heterocycle.
You may match. Also added to the right shoulder of the substituent A is
It shows that the substituent A has a monovalent positive charge. Replaced
Optionally forming a condensed ring at the 2,3-position or the 3,4-position.
Midarium-1-yl group (A ) Example above
Hydrocarbon group (R2) And acyl groups (R1) Has been replaced
Good imidazo [1,2-a] pyridinium-1-yl groupImidazo [1,2-b] pyridazinium-1-yl groupImidazo [1,5-a] pyridinium-2-yl groupCan be given.
上記図式で示される方法は、化合物(VI)またはその塩
を化合物(I)またはその塩もしくは反応性誘導体でア
シル価する方法である。この方法において化合物(I)
は遊離のままあるいはその塩もしくは反応性誘導体が化
合物(VI)の7位アミノ基のアシル化剤として用いられ
る。すなわち化合物(I)あるいは化合物(I)の無機
塩基塩,有機塩基塩や酸ハライド,酸アジド,酸無水
物,混合酸無水物,活性アミド,活性エステル,活性チ
オエステルなどの反応性誘導体がアシル化反応に供され
る。無機塩基塩としてはアルカリ金属塩(たとえばナト
リウム塩,カリウム塩など),アルカリ土類金属塩(た
とえばカルシウム塩など)などが、有機塩基塩としては
たとえばトリメチルアミン塩,トリエチルアミン塩,ter
t−ブチルジメチルアミン塩,ジベンジルメチルアミン
塩,ベンジルジメチルアミン塩,N,N−ジメチルアニリン
塩,ピリジン塩,キノリン塩などが、酸ハライドとして
はたとえば酸クロライド,酸ブロマイドなどが、混合酸
無水物としてはモノアルキル炭酸混合酸無水物,脂肪族
カルボン酸混合酸無水物,芳香族カルボン酸混合酸無水
物などが、活性アミドとしては含窒素複素環化合物
(例、ベンゾトリアゾール)とのアミドなどが用いられ
る。活性エステルとしてはβ−ラクタムおよびペブチド
合成の分野でこの目的に用いられるものはすべて利用で
き、たとえば有機リン酸エステルのほかp−ニトロフェ
ニルエステル,2,4−ジニトロフェニルエステル,シアノ
メチルエステル,ペンタクロロフェニルエステル,N−ヒ
ドロキシサクシンイミドエステル,N−ヒドロキシフタル
イミドエステル,1−ヒドロキシベンゾトリアゾールエス
テル,6−クロロ−1−ヒドロキシベンゾトリアゾールエ
ステル,1−ヒドロキシ−1H−2−ピリドンエステルなど
が用いられる。活性チオエステルとしては芳香族複素環
チオール化合物とのエステルが用いられる。化合物(V
I)は遊離のまま、あるいはその塩として用いられる。
化合物(VI)の塩としては無機塩基塩,有機塩基塩,無
機酸付加塩,有機酸付加塩などが用いられる。無機塩基
塩としてはアルカリ金属塩(たとえばナトリウム塩,カ
リウム塩など),アルカリ土類金属塩(たとえばカルシ
ウム塩など)などが、有機塩基塩としてはたとえばトリ
メチルアミン塩,トリエチルアミン塩,tert−ブチルジ
メチルアミン塩,ジベンジルメチルアミン塩,ベンジル
ジメチルアミン塩,N,N−ジメチルアニリン塩,ピリジン
塩,キノリン塩などが、無機酸付加塩としてはたとえば
塩酸塩,臭化水素酸塩,硫酸塩,硝酸塩,リン酸塩など
が、有機酸付加塩としてはギ酸塩,酢酸塩,トリフルオ
ロ酢酸塩,メタンスルホン酸塩,p−トルエンスルホン酸
塩などが用いられる。化合物(I)の反応性誘導体は公
知の方法またはそれに準ずる方法によって容易に製造で
きる。化合物(I)の反応性誘導体は反応混合物から単
離された物質として化合物(VI)またはその塩と反応さ
せてもよいし、または単離前の化合物(I)の反応性誘
導体を含有する反応混合物をそのまま化合物(VI)また
はその塩と反応させることもできる。化合物(I)を遊
離酸または塩の状態で使用する場合は適当な縮合剤を用
いる。縮合剤としてはたとえばN,N′−ジシクロヘキシ
ルカルボジイミドなどのN,N′−ジ置換カルボジイミド
類,たとえばN,N′−カルボニルジイミダゾール,N,N′
−チオカルボニルジイミダゾールなどのアゾライド類,
たとえばN−エトキシカルボニル−2−エトキシ−1,2
−ジヒドロキノリン,オキシ塩化リン,アルコキシアセ
チレンなどの脱水剤,たとえば2−クロロ−1−メチル
ピリジニウム アイオダイド,2−フルオロ−1−メトル
ピリジニウム アイオダイドなどの2−ハロゲノピリジ
ニウム塩類などが用いられる。反応は一般に溶媒中で行
なわれ、反応を阻害しない溶媒が適宜に選択される。こ
のような溶媒としてはたとえばジオキサン,テトラヒド
ロフラン,ジエチルエーテル,tert−ブチルメチルエー
テル,ジイソプロピルエーテル,エチレングリコール−
ジメチルエーテルなどのエーテル類,たとえばギ酸エチ
ル,酢酸エチル,酢酸n−ブチルなどのエステル類,た
とえばジクロロメタン,クロロホルム,四塩化炭素,ト
リクレン,1,2−ジクロロエタンなどのハロゲン化炭化水
素類,たとえばn−ヘキサン,ベンゼン,トルエンなど
の炭化水素類,たとえばホルムアミド,N,N−ジメチルホ
ルムアミド,N,N−ジメチルアセトアミドなどのアミド
類,たとえばアセトン,メチルエチルケトン,メチルイ
ソブチルケトンなどのケトン類,たとえばアセトニトリ
ル,プロピオニトリルなどのニトリル類などのほか,ジ
メチルスルホキシド,スルホラン,ヘキサメチルホスホ
ルアミド,水などが単独または混合溶媒として用いられ
る。化合物(I)またはその塩、または反応性誘導体の
使用量は化合物(VI)またはその塩1モルに対して通常
約1から5モル量,好ましくは約1から2モル量であ
る。反応は約−80から80℃,好ましくは約−40から50
℃,最も好ましくは約−30から30℃の温度範囲で行われ
る。反応時間は通常約1分から72時間,好ましくは約15
分から3時間である。化合物(I)として酸ハライドを
用いた場合は放出されるハロゲン化水素を反応系から除
去する目的で脱酸剤の存在下に反応を行うことができ
る。このような脱酸剤としてはたとえば炭酸ナトリウ
ム,炭酸カリウム,炭酸カルシウム,炭酸水素ナトリウ
ムなどの無機塩基,たとえばトリエチルアミン,トリ
(n−プロピル)アミン,トリ(n−ブチル)アミン,
ジイソプロピルエチルアミン,シクロヘキシルジメチル
アミン,ピリジン,ルチジン,γ−コリジン,ピリコ
ン,N,N−ジメチルアニリン,N−メチルピペジリン,N−メ
チルピロリジン,N−メチルモルホリンなどの第3級アミ
ン,たとえばプロピレンオキシド,エピクロルヒドリン
などのアルキレンオキシドなどが用いられる。The method represented by the above scheme is a method of acylating compound (VI) or a salt thereof with compound (I) or a salt or a reactive derivative thereof. In this method, compound (I)
Is used as it is or as a salt or a reactive derivative thereof as an acylating agent for the 7-position amino group of the compound (VI). That is, the reactive derivative such as the compound (I) or an inorganic base salt, an organic base salt, an acid halide, an acid azide, an acid anhydride, a mixed acid anhydride, an active amide, an active ester or an active thioester of compound (I) is acylated. Subject to the reaction. Inorganic base salts include alkali metal salts (eg, sodium salt, potassium salt, etc.), alkaline earth metal salts (eg, calcium salt, etc.), and organic base salts include, for example, trimethylamine salt, triethylamine salt, ter.
t-Butyldimethylamine salt, dibenzylmethylamine salt, benzyldimethylamine salt, N, N-dimethylaniline salt, pyridine salt, quinoline salt and the like, and acid halides such as acid chloride and acid bromide are mixed acid anhydrides. Examples of the compound include monoalkyl carbonic acid mixed acid anhydride, aliphatic carboxylic acid mixed acid anhydride, aromatic carboxylic acid mixed acid anhydride, and the like, and active amides include amides with nitrogen-containing heterocyclic compounds (eg, benzotriazole). Is used. As the active ester, all those used for this purpose in the field of β-lactam and pebutide synthesis can be used, and examples thereof include organic phosphoric acid esters as well as p-nitrophenyl ester, 2,4-dinitrophenyl ester, cyanomethyl ester, pentaester. Chlorophenyl ester, N-hydroxysuccinimide ester, N-hydroxyphthalimide ester, 1-hydroxybenzotriazole ester, 6-chloro-1-hydroxybenzotriazole ester, 1-hydroxy-1H-2-pyridone ester and the like are used. As the active thioester, an ester with an aromatic heterocyclic thiol compound is used. Compound (V
I) is used as a free salt or as a salt thereof.
As the salt of the compound (VI), an inorganic base salt, an organic base salt, an inorganic acid addition salt, an organic acid addition salt and the like are used. Inorganic base salts include alkali metal salts (eg sodium salt, potassium salt, etc.), alkaline earth metal salts (eg calcium salt, etc.), and organic base salts include, for example, trimethylamine salt, triethylamine salt, tert-butyldimethylamine salt. , Dibenzylmethylamine salt, benzyldimethylamine salt, N, N-dimethylaniline salt, pyridine salt, quinoline salt, and the like, and inorganic acid addition salts include, for example, hydrochloride, hydrobromide, sulfate, nitrate, phosphorus. As the organic acid addition salt, formate salt, acetate salt, trifluoroacetate salt, methanesulfonate salt, p-toluenesulfonate salt and the like are used. The reactive derivative of compound (I) can be easily produced by a known method or a method analogous thereto. The reactive derivative of compound (I) may be reacted with compound (VI) or a salt thereof as a substance isolated from the reaction mixture, or a reaction containing the reactive derivative of compound (I) before isolation. The mixture can be directly reacted with the compound (VI) or a salt thereof. When the compound (I) is used in the free acid or salt form, a suitable condensing agent is used. Examples of the condensing agent include N, N'-disubstituted carbodiimides such as N, N'-dicyclohexylcarbodiimide, such as N, N'-carbonyldiimidazole, N, N '.
-Azolides such as thiocarbonyldiimidazole,
For example, N-ethoxycarbonyl-2-ethoxy-1,2
A dehydrating agent such as dihydroquinoline, phosphorus oxychloride, or alkoxyacetylene, for example, 2-halogenopyridinium salt such as 2-chloro-1-methylpyridinium iodide or 2-fluoro-1-methorpyridinium iodide is used. The reaction is generally performed in a solvent, and a solvent that does not inhibit the reaction is appropriately selected. Examples of such a solvent include dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether, ethylene glycol-
Ethers such as dimethyl ether, esters such as ethyl formate, ethyl acetate, n-butyl acetate, etc., halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, trichlene, 1,2-dichloroethane, such as n-hexane. , Hydrocarbons such as benzene and toluene, amides such as formamide, N, N-dimethylformamide, N, N-dimethylacetamide, and ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, such as acetonitrile and propionitrile In addition to nitriles such as dimethyl sulfoxide, sulfolane, hexamethylphosphoramide, water, etc. are used alone or as a mixed solvent. The amount of compound (I) or its salt or reactive derivative used is usually about 1 to 5 mol, preferably about 1 to 2 mol, per 1 mol of compound (VI) or its salt. The reaction is about -80 to 80 ° C, preferably about -40 to 50
C., most preferably in the temperature range of about -30 to 30.degree. The reaction time is usually about 1 minute to 72 hours, preferably about 15
3 minutes to 3 hours. When an acid halide is used as the compound (I), the reaction can be carried out in the presence of a deoxidizing agent for the purpose of removing released hydrogen halide from the reaction system. Examples of such a deoxidizing agent include inorganic bases such as sodium carbonate, potassium carbonate, calcium carbonate and sodium hydrogen carbonate, such as triethylamine, tri (n-propyl) amine, tri (n-butyl) amine,
Tertiary amines such as diisopropylethylamine, cyclohexyldimethylamine, pyridine, lutidine, γ-collidine, pyricon, N, N-dimethylaniline, N-methylpiperidine, N-methylpyrrolidine and N-methylmorpholine, eg propylene oxide, epichlorohydrin, etc. Alkylene oxides and the like are used.
このようにして得られるアゼチジノン化合物,セファロ
スポリン化合物及びペニシリン化合物またはこれらの塩
(例えば塩酸,硫酸,リン酸などの無機酸、例えばマレ
イン酸,酢酸,クエン酸,酒石酸,リンゴ酸,マロン
酸,フマル酸,安息香酸,マンデル酸,アスコルビン
酸,メタンスルホン酸等の有機酸等との塩)は、自体公
知の単離精製手段(例えば結晶化,再結晶,クロマトグ
ラフィー等)により単離精製することができる。Thus obtained azetidinone compound, cephalosporin compound and penicillin compound or salts thereof (for example, inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, for example, maleic acid, acetic acid, citric acid, tartaric acid, malic acid, malonic acid, Fumaric acid, benzoic acid, mandelic acid, ascorbic acid, salts with organic acids such as methanesulfonic acid) are isolated and purified by a known isolation and purification means (eg, crystallization, recrystallization, chromatography, etc.). be able to.
このようにして得られるアゼチジノン化合物,セファロ
スポリン化合物及びペニシリン化合物は、人及び哺乳動
物の細菌(例えば、グラム陽性菌たとえばスタフィロコ
ッカス・アウレウス(Staphylococcus aureus)、グラ
ム陰性菌たとえばエシェリヒア・コリ(Escherichia co
li)、クレーブジーラ・ニューモニアエ(Klebsiella p
neumoniae)、プロテウス・ブルガリス(Proteus vulga
ris)、プロテウス・ミラビリス(Proteus mirabili
s)、プロテウス・モルガニイ(Proteus morganii)、
シュードモナス・エルギノーザ(Pseudomonas aerugino
sa))感染症の治療、例えば細菌起炎性の呼吸器感染症
および尿路感染症等の治療に有効である。The azetidinone compound, cephalosporin compound and penicillin compound thus obtained are used for human and mammalian bacteria (for example, Gram-positive bacteria such as Staphylococcus aureus, Gram-negative bacteria such as Escherichia coli). co
li), Klebsiella p.
neumoniae), Proteus vulga
ris), Proteus mirabili
s), Proteus morganii,
Pseudomonas aerugino
sa)) It is effective for the treatment of infectious diseases such as bacterial respiratory respiratory infections and urinary tract infections.
原料化合物(V)またはその塩は例えば下記方法によっ
て製造される。即ち3−アミジノクマリン化合物(VII
I)をハロゲン化剤と反応させてN−ハロアミジノクマ
リン化合物(IX)とし、ついでチオシアン酸塩とを反応
させることにより製造される。The raw material compound (V) or a salt thereof is produced, for example, by the following method. That is, 3-amidinocoumarin compound (VII
It is produced by reacting I) with a halogenating agent to give an N-haloamidinocoumarin compound (IX), and then reacting with thiocyanate.
[式中Xは塩素,ヨウ素等のハロゲン原子,他の記号は
前記と同意義を示す] (VIII)のハロゲン化反応は溶媒、例えばメタノール,
エタノールなどのアルコール類,酢酸エチルなどのエス
テル類,ジオキサン,ジメトキシエタン,ジエチルエー
テル,テトラヒドロフランなどのエーテル類,メチレン
クロリドなどのハロゲン化炭素水素およびこれらと水と
の混合溶媒(中でもメタノールが好ましい)中、等モル
のハロゲン化剤を反応させることにより行うことができ
る。ハロゲン化剤としては塩素,臭素などのハロゲン,N
−クロロサクシンイミド,クロラミンT,N−クロロフタ
ルイミドなどのN−ハロゲノアミド,次亜塩素酸および
その塩(カルシウム塩,ナトリウム塩,カリウム塩)お
よびその水溶液,tert−ブチルハイポクロライト,ヨー
ドベンゼンジクロライドなどの活性ハロゲン供与体が用
いられる。(VIII)は遊離塩基としても、または塩(塩
酸塩,酢酸塩)としても用いることができる。(VIII)
を塩の形で用いる場合には反応液中に等モル以上のトリ
エチルアミンなどの有機3級アミン,ナトリウムメロト
キシドなどの金属アルコキシド,水酸化ナトリウム,水
酸化カリウム,炭酸カリウム,重炭酸ナトリウム,酢酸
ナトリウム,酢酸カリウムなどの無機塩基を加えてもよ
い。反応は−10から30℃,好ましくは−5から20℃で行
なうのがよい。生成する(IX)は反応液のまゝ次工程の
反応に用いてもよいが、ろ取,または抽出等の通常の手
段により反応液から取り出すこともできる。 [In the formula, X is a halogen atom such as chlorine and iodine, and other symbols have the same meanings as described above] The halogenation reaction of (VIII) is performed by using a solvent such as methanol,
In alcohols such as ethanol, esters such as ethyl acetate, ethers such as dioxane, dimethoxyethane, diethyl ether, tetrahydrofuran, halogenated carbon hydrogen such as methylene chloride, and a mixed solvent of these and water (methanol is preferable among them) Can be performed by reacting equimolar halogenating agents. As halogenating agents, halogens such as chlorine and bromine, N
-Chlorosuccinimide, chloramine T, N-halogenamides such as N-chlorophthalimide, hypochlorous acid and its salts (calcium salt, sodium salt, potassium salt) and its aqueous solution, tert-butyl hypochlorite, iodobenzene dichloride Active halogen donors such as (VIII) can be used as a free base or as a salt (hydrochloride, acetate). (VIII)
When used in the form of a salt, equimolar amounts of organic tertiary amines such as triethylamine, metal alkoxides such as sodium methoxide, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium bicarbonate, acetic acid are used in the reaction solution. An inorganic base such as sodium or potassium acetate may be added. The reaction is carried out at -10 to 30 ° C, preferably -5 to 20 ° C. The produced (IX) may be used for the reaction in the next step of the reaction solution, but can also be taken out from the reaction solution by a usual means such as filtration or extraction.
(IX)をついで等モルのチオシアン酸塩(例:チオシア
ン酸カリウム,チオシアン酸ナトリウム,チオシアン酸
アンモニウムなど)と反応させる。反応は溶媒中行なう
のがよく、溶媒としては、アルコール類(例:メタノー
ル,エタノールなど),ケトン類(例:アセトンな
ど),エーテル類(例:ジオキサン,テトラヒドロフラ
ンなど),アミド類(例:ジメチルホルムアミド,ジメ
チルアセトアミドなど),アセトニトリル,ジメチルス
ルホキシド,スルホランなどおよびこれらの混合溶媒が
用いられるが、なかでもメタノール−アセトン,メタノ
ール−ジメチルホルムアミドなどが好ましい。反応温度
は0から100℃,好ましくは0から60℃,反応時間は溶
媒,反応温度などによるがおゝむね0.5時間ないし24時
間(例えばメタノール−ジメチルホルムアミド溶媒で反
応温度40℃のとき約1時間位,メタノール−アセトン溶
媒で室温で反応させるとき約8−16時間など)である。(IX) is then reacted with an equimolar amount of thiocyanate (eg potassium thiocyanate, sodium thiocyanate, ammonium thiocyanate, etc.). The reaction is preferably carried out in a solvent. As the solvent, alcohols (eg, methanol, ethanol, etc.), ketones (eg, acetone, etc.), ethers (eg, dioxane, tetrahydrofuran, etc.), amides (eg, dimethyl) Formamide, dimethylacetamide, etc.), acetonitrile, dimethylsulfoxide, sulfolane, etc. and a mixed solvent thereof are used, and among them, methanol-acetone, methanol-dimethylformamide and the like are preferable. The reaction temperature is 0 to 100 ° C, preferably 0 to 60 ° C, and the reaction time depends on the solvent, the reaction temperature, etc., but is generally 0.5 hours to 24 hours (for example, about 1 hour at a reaction temperature of 40 ° C in a methanol-dimethylformamide solvent). Approximately 8 to 16 hours when the reaction is carried out at room temperature with a methanol-acetone solvent).
このようにして得られる化合物(IX),(V)またはそ
の塩は自体公知の単離精製手段(例、結晶化,再結晶,
クロマトグラフィー等)により単離精製できる。The compound (IX), (V) or a salt thereof thus obtained can be isolated and purified by a known means (eg, crystallization, recrystallization,
It can be isolated and purified by chromatography).
実施例,参考例 実施例中の記号は次のような意味を有する。Examples and Reference Examples The symbols in the examples have the following meanings.
s:シングレット(singlet) d:ダブレット(doublet) t:トリプレツト(triplet) q:クワルテット(quartet) ABq:AB型クワルテット(AB type quartet) d.d:ダブル ダブレット(double doublet) m:マルチプレット(multiplet) br:ブロード(broad) J:カップリング定数(coupling constant) DMSO:ジメチルスルホキシド 参考例1 3−(N−クロロアミジノ)クマリン 3−アミジノクマリン塩酸塩※224g,N−クロロスクシン
イミド130gをメタノール2.5lに懸濁し、激しく攪拌す
る。内温を10から16℃にたもちながらトリエチルアミン
140mlを滴下する。氷冷下,30分攪拌後,析出した粉末を
ろ取し、乾燥して3−(N−クロロアミジノ)クマリン
の粉末140gを得る。m.p 180−185℃(分解) 元素分析値:C10H7N2O2Clとして 計算値(%):C,53.95; H,3.17; N,12,58 実測値(%);C,53.81; H,3.07; N,12.59 ※ブレティン・オブ・ザ・ケミカル・ソサイアティ・オ
ブ・ジャパン(Bull.Chem.Soc.Jap.)1970年4319巻2925
頁に記載 参考例2 3−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)クマリン 3−(N−クロロアミジノ)クマリン140g,チオシアン
酸カリウム76g,メタノール1.26l,アセトン630mlからな
る懸濁液を16時間,室温で攪拌する。反応液をろ過し析
出した結晶をろ取、結晶を水でよく洗った後、乾燥し標
記化合物109gを得る。m.p220−228℃(分解) 元素分析値:C11H7N3O2Sとして 計算値(%):C,53.87; H,2.88; N,17.13 実測値(%);C,53.99; H,2.77; N,17.13 NMRスペクトル(d6−DMSO)δ:7.23〜7.57(4H,m),7.9
7(2H,s),8.58(9H,s) 参考例3 7β−[2−(5−アミノ−1,2,4−チアジアゾール−
3−イル)−2(Z)−メトキシイミノアセトアミド]
−3−(3−オキソブチリルオキシメチル)−3−セフ
ェム−4−カルボン酸 7β−アミノ−3−(3−オキソブチリルオキシメチ
ル)−3−セフェム−4−カルボン酸9.06gをジクロル
メタン200mlに懸濁し、これにビストリメチルシリルア
セトアミド28.9gを加えて室温で溶液となるまでかきま
ぜる。ついで氷冷し、これに、2−(5−アミノ−1,2,
4−チアジアゾール−3−イル)−2(Z)−メトキシ
イミノアセチルクロリドのジクロルメタン溶液(2−
(5−アミノ−1,2,4−チアジアゾール−3−イル)−
2(Z)−メトキシイミノ酢酸5.83gと五塩化燐6.02gと
からジクロルメタン90ml中調製したもの)を加え、氷冷
下に1時間かきまぜる。ジクロルメタンを留去し、残留
物をメチルエチルケトンと水に溶かし、有機層を分液
し、水洗・乾燥後溶媒を留去する。残留物にジエチルエ
ーテルを加えて粉末とし、これをろ取し、標記化合物1
1.8g(収率82%)を得る。s: singlet d: doublet t: triplet q: quartet AB q: AB type quartet dd: double doublet m: multiplet br : Broad J: coupling constant DMSO: dimethyl sulfoxide Reference Example 1 3- (N-chloroamidino) coumarin 3-amidinocoumarin hydrochloride * 224 g, N-chlorosuccinimide 130 g suspended in 2.5 l of methanol. It becomes cloudy and vigorously stirred. Keeping the internal temperature at 10 to 16 ℃, triethylamine
Add 140 ml dropwise. After stirring for 30 minutes under ice cooling, the precipitated powder was collected by filtration and dried to obtain 140 g of 3- (N-chloroamidino) coumarin powder. mp 180-185 ° C (decomposition) Elemental analysis: Calculated as C 10 H 7 N 2 O 2 Cl (%): C, 53.95; H, 3.17; N, 12,58 Measured value (%); C, 53.81 H, 3.07; N, 12.59 * Bulletin of the Chemical Society of Japan (Bull.Chem.Soc.Jap.) 1970 4319 Vol. 2925
Reference Example 2 3- (5-amino-1,2,4-thiadiazol-3-yl) coumarin 140 g of 3- (N-chloroamidino) coumarin, 76 g of potassium thiocyanate, 1.26 l of methanol and 630 ml of acetone The suspension is stirred for 16 hours at room temperature. The reaction solution was filtered and the precipitated crystals were collected by filtration, washed well with water, and dried to give 109 g of the title compound. m.p 220-228 ℃ (decomposition) Elemental analysis value: Calculated as C 11 H 7 N 3 O 2 S (%): C, 53.87; H, 2.88; N, 17.13 Measured value (%); C, 53.99; H, 2.77; N, 17.13 NMR spectrum (d 6 -DMSO) δ: 7.23 to 7.57 (4H, m), 7.9
7 (2H, s), 8.58 (9H, s) Reference Example 3 7β- [2- (5-amino-1,2,4-thiadiazole-
3-yl) -2 (Z) -methoxyiminoacetamide]
-3- (3-oxobutyryloxymethyl) -3-cephem-4-carboxylic acid 7β-amino-3- (3-oxobutyryloxymethyl) -3-cephem-4-carboxylic acid 9.06 g of dichloromethane 200 ml 28.9 g of bistrimethylsilylacetamide, and stir at room temperature until it becomes a solution. Then, it was ice-cooled, and 2- (5-amino-1,2,
4-Thiadiazol-3-yl) -2 (Z) -methoxyiminoacetyl chloride solution in dichloromethane (2-
(5-amino-1,2,4-thiadiazol-3-yl)-
2 (Z) -methoxyiminoacetic acid (5.83 g) and phosphorus pentachloride (6.02 g) prepared in 90 ml of dichloromethane) were added, and the mixture was stirred for 1 hour under ice cooling. Dichloromethane is distilled off, the residue is dissolved in methyl ethyl ketone and water, the organic layer is separated, washed with water and dried, and then the solvent is distilled off. Diethyl ether was added to the residue to give a powder, which was collected by filtration to give the title compound 1
1.8 g (82% yield) are obtained.
NMRスペクトル(d6−DMSO)δ:2.19(3H,s),3.40と3.6
5(2H,ABq,J=18Hz),3.63(2H,s),3.95(3H,s),4.78
と5.09(2H,ABq,J=14Hz),5.14(1H,d,J=4.8Hz),5.8
4(1H,d.d,J=8Hzと4.8Hz),8.11(2H,br.),9.59(1H,
d,J=8Hz) 参考例4 7β−[2−(5−アミノ−1,2,4−チアジアゾール−
3−イル)−2(Z)−メトキシイミノアセトアミド]
−3−[(イミダゾ[1,2−b]ピリダジニウム−1−
イル)メチル]−3−セフェム−4−カルボキシレート 7β−[2−(5−アミノ−1,2,4−チアジアゾール−
3−イル)−2(Z)−メトキシイミノアセトアミド]
−3−(3−オキソブチリルオキシメチル)−3−セフ
ェム−4−カルボン酸1.1g,イミダゾ[1,2−b]ピリジ
ン1.0g,ヨウ化カリウム1.1gを50%含水アセトニトリル3
0mlに溶解し、60〜70℃で2時間攪拌する。冷却後、反
応液をシリカゲルカラムクロマトグラフィーに付し、ア
セトン,含水アセトンで順次溶出し、目的物を含む分画
を合わせ減圧下に溶媒を濃縮する。残渣をMCIゲルCHP 2
0P 樹脂(三菱化成製)によるカラムクロマトグラフィ
ーに付し、水,次いで含水アルコールで溶出し、目的物
を含む分画を合わせ減圧下に濃縮した後、残渣を凍結乾
燥し、標記化合物を得る。 NMR spectrum (d6−DMSO) δ: 2.19 (3H, s), 3.40 and 3.6
5 (2H, ABq, J = 18Hz), 3.63 (2H, s), 3.95 (3H, s), 4.78
And 5.09 (2H, ABq, J = 14Hz), 5.14 (1H, d, J = 4.8Hz), 5.8
4 (1H, d.d, J = 8Hz and 4.8Hz), 8.11 (2H, br.), 9.59 (1H,
d, J = 8 Hz) Reference Example 4 7β- [2- (5-amino-1,2,4-thiadiazole-
3-yl) -2 (Z) -methoxyiminoacetamide]
-3-[(imidazo [1,2-b] pyridazinium-1-
Iyl) methyl] -3-cephem-4-carboxylate 7β- [2- (5-amino-1,2,4-thiadiazole-
3-yl) -2 (Z) -methoxyiminoacetamide]
-3- (3-oxobutyryloxymethyl) -3-cef
Em-4-carboxylic acid 1.1 g, imidazo [1,2-b] pyridy
1.0 g of potassium iodide and 1.1 g of potassium iodide 50% hydrous acetonitrile 3
Dissolve in 0 ml and stir at 60-70 ° C for 2 hours. After cooling, anti
Apply the reaction solution to silica gel column chromatography and
Fraction containing the desired product, eluting sequentially with seton and hydrous acetone
And the solvent is concentrated under reduced pressure. The residue is MCI gel CHP 2
0P Column chromatography with resin (manufactured by Mitsubishi Kasei)
And elute with water and then with hydrous alcohol to obtain the desired product.
The fractions containing were combined and concentrated under reduced pressure, and the residue was freeze-dried.
Dry to obtain the title compound.
元素分析値:C19H17N9O5S2・3H2Oとして 計算値(%):C,40.07;H,4.07;N,22.13 実測値(%):C,39.75;H,3.51;N,21.89 NMRスペクトル(d6−DMSO)δ:3.03と3.44(2H,ABq,J=
18Hz),3.86(3H,s),4.99(1H,d,J=4.5Hz),5.27と5.
51(2H,ABq,J=14Hz),5.63(1H,d.d,J=4.5Hzと8Hz),
7.8-8.32(1H,m),8.12(2H,br.s),8.76(2H,s),9.04
(1H,d,J=4Hz),9.31(1H,d,J=9Hz),9.44(1H,d,J=
8Hz) 実施例1 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−2(Z)−メトキシイミノ酢酸 (1)3−(5−アミノ−1,2,4−チアジアゾール−3
−イル)−クマリン12gをエタノール100mlに懸濁し、一
規定苛性ソーダ水溶液100mlを加え、室温で60分攪拌す
る。酢酸エチル250mlを加え、氷冷下に一規定塩酸100ml
で中和する。食塩を飽和し、酢酸エチル層を分取し、2
−(5−アミノ−1,2,4−チアジアゾール−3−イル)
−2(Z)−(2−ヒドロキベンジリデン)−酢酸の酢
酸エチル溶液を得る。Elemental analysis: C 19 H 17 N 9 O 5 S 2 · 3H 2 O Calculated (%): C, 40.07; H, 4.07; N, 22.13 Found (%): C, 39.75; H, 3.51; N, 21.89 NMR spectrum (d 6 -DMSO) δ: 3.03 and 3.44 (2H, ABq, J =
18Hz), 3.86 (3H, s), 4.99 (1H, d, J = 4.5Hz), 5.27 and 5.
51 (2H, ABq, J = 14Hz), 5.63 (1H, dd, J = 4.5Hz and 8Hz),
7.8-8.32 (1H, m), 8.12 (2H, br.s), 8.76 (2H, s), 9.04
(1H, d, J = 4Hz), 9.31 (1H, d, J = 9Hz), 9.44 (1H, d, J =
8 Hz) Example 1 2- (5-Amino-1,2,4-thiadiazol-3-yl) -2 (Z) -methoxyiminoacetic acid (1) 3- (5-Amino-1,2,4-thiadiazole -3
-Yl) -Coumarin (12 g) is suspended in 100 ml of ethanol, 100 ml of a 1N sodium hydroxide aqueous solution is added, and the mixture is stirred at room temperature for 60 minutes. 250 ml of ethyl acetate was added, and 100 ml of 1N hydrochloric acid was added under ice cooling.
Neutralize with. Saturate the salt, separate the ethyl acetate layer, and
-(5-amino-1,2,4-thiadiazol-3-yl)
A solution of -2 (Z)-(2-hydroxybenzylidene) -acetic acid in ethyl acetate is obtained.
(2)上記で得られる溶液をドライアイス−アセトン
(−78℃)浴にて冷却しながらオゾンを通じる。反応終
了後、水90mlを加え激しく攪拌する。水層を分取して2
−(5−アミノ−1,2,4−チアジアゾール−3−イル)
−2−オキソ酢酸水溶液を得る。(2) Ozone is passed while cooling the solution obtained above in a dry ice-acetone (-78 ° C) bath. After the reaction is complete, add 90 ml of water and stir vigorously. Separate the water layer 2
-(5-amino-1,2,4-thiadiazol-3-yl)
A 2-oxoacetic acid aqueous solution is obtained.
(3)これに攪拌しながらO−メチルヒドロキシルアミ
ン塩酸塩5g,酢酸ナトリウム8gを一度に加え、室温で3
時間攪拌する。エーテルで洗浄後、水層を減圧下に濃縮
し、メチルエチルケトン300mlを加え、氷冷下攪拌す
る。一規定塩酸50mlを加え、食塩を飽和した後、有機層
を分取する。無水硫酸マグネシウムで乾燥後、溶媒を減
圧下に留去する。結晶化した残渣を少量の酢酸エチルで
ほぐしてろ取し、標記化合物6.1gを得る。(3) While stirring, add 5 g of O-methylhydroxylamine hydrochloride and 8 g of sodium acetate at once, and stir at room temperature for 3 hours.
Stir for hours. After washing with ether, the aqueous layer is concentrated under reduced pressure, 300 ml of methyl ethyl ketone is added, and the mixture is stirred under ice cooling. 50 ml of 1N hydrochloric acid is added to saturate the salt, and the organic layer is separated. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The crystallized residue is triturated with a small amount of ethyl acetate and collected by filtration to obtain 6.1 g of the title compound.
m.p178℃(分解) NMRスペクトル(d6−DMSO)δ:3.97(3H,s),8.10(2H,
br.s) 実施例2 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−2(Z)−メトキシイミノ酢酸 (1)3−(5−アミノ−1,2,4−チアジアゾール−3
−イル)−クマリン24.5gをエタノール200mlに懸濁し、
一規定苛性ソーダ200mlを加える。約40℃の湯浴上で60
分間加温しながら攪拌し、均一浴液を得る。氷冷しクロ
ル炭酸エチルエステル11gを一度に添加し氷冷下5分攪
拌する。ジクロメタン300mlを加え、氷冷下に一規定塩
酸100mlを加える。ジクロルメタン層を分取し、水層を
ジクロルメタン200mlで抽出後、ジクロルメタン層を合
わせ、2−(5−アミノ−1,2,4−チアジアゾール−3
−イル)−2(Z)−(2−エトキシカルボニルオキシ
ベンジリデン)酢酸のジクロルメタン溶液を得る。m.p178 ℃ (decomposition) NMR spectrum (d 6 -DMSO) δ: 3.97 (3H, s), 8.10 (2H,
br.s) Example 2 2- (5-amino-1,2,4-thiadiazol-3-yl) -2 (Z) -methoxyiminoacetic acid (1) 3- (5-amino-1,2,4 -Thiadiazole-3
-Yl) -Coumarin 24.5 g suspended in 200 ml of ethanol,
Add 200 ml of 1N caustic soda. 60 on a hot water bath at about 40 ℃
Stir while heating for a minute to obtain a uniform bath liquid. After ice cooling, 11 g of chlorocarbonic acid ethyl ester was added all at once and the mixture was stirred for 5 minutes under ice cooling. Add 300 ml of dichloromethane and add 100 ml of 1N hydrochloric acid under ice cooling. The dichloromethane layer was separated, the aqueous layer was extracted with 200 ml of dichloromethane, the dichloromethane layers were combined, and 2- (5-amino-1,2,4-thiadiazole-3 was used.
A solution of -yl) -2 (Z)-(2-ethoxycarbonyloxybenzylidene) acetic acid in dichloromethane is obtained.
(2)上記溶液をドライアイス−アセトン浴(−78℃)
で冷却し、オゾンを反応液が青くなるまで通じる。酢酸
ソーダ8.2gを加え、冷浴を外し、窒素ガスで瀑気後、ジ
クロルメタン層を水200ml,100mlで2回抽出する。水層
を酢酸エチル200mlで洗浄し、2−(5−アミノ−1,2,4
−チアゾール−3−イル)−2−オキソ酢酸の水溶液を
得る。(2) Dry ice-acetone bath (-78 ° C)
Cool with and let ozone flow until the reaction liquid turns blue. 8.2 g of sodium acetate was added, the cold bath was removed, and after nitrogen gas was evacuated, the dichloromethane layer was extracted twice with 200 ml of water and 100 ml of water. The aqueous layer was washed with 200 ml of ethyl acetate to give 2- (5-amino-1,2,4
An aqueous solution of -thiazol-3-yl) -2-oxoacetic acid is obtained.
(3)上記溶液に室温で攪拌しながら、O−メチルヒド
ロキシルアミン塩酸塩9.1g,酢酸ナトリウム9gを加え、
3時間攪拌後一夜室温で放置する。酸性亜硫酸ソーダ1.
2gを加え、減圧下約150mlに濃縮する。メチルエチルケ
トン200mlを加え、氷冷下に攪拌しながら濃塩酸10mlを
加える。水層をメチルエチルケトン100mlで2回抽出
し、有機層を合わせて無水硫酸マグネシウムで乾燥す
る。減圧下に溶媒を留去して得られる結晶を少量の酢酸
エチルでほぐしてろ取する。母液を濃縮して得られる第
二結晶を合わせて標記化合物10.2gを得る。m.p178℃
(分解) NMRスペクトル(d6−DMSO)δ:3.97(3H,s),8.10(2H,
br.s) 実施例3 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−2(Z)−(2−エトキシカルボニルオキシベン
ジリデン)酢酸 3−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−クマリン4.9gをエタノール40mlに懸濁し、一規定
苛性ソーダ40mlを加える。約60℃の湯浴上15分加温し、
2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−2(Z)−(2−ヒドロキシベンジリデン)−酢
酸2ナトリウム塩溶液を得る。これに氷冷下氷冷下、ク
ロルギ酸エチルエステル2.2gを加え、10分間氷冷下に攪
拌する。酢酸エチル60ml,一規定塩酸20mlを加え、激し
く攪拌する。酢酸エチル層を分取し、無水硫酸マグネシ
ウムで乾燥し、減圧下に溶媒を留去する。結晶ヲエーテ
ルでほぐしてろ取し、標記化合物4.6gを得る。m.p 175
℃(分解) 元素分析値:C14H13N3O5Sとして 計算値(%):C,50.14; H,3.91; N,12.53 実測値(%):C,49.63; H,3.84; N,12.30 NMRスペクトル(d6−DMSO)δ:1.32(3H,t,J=7.5Hz),
4.30(2H,q,J=7.5Hz),7.20〜7.80(4H,m),7.55(1H,
s),8.00(2H,s) 実施例4 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−2(Z)−(2−アセトキシベンジリデン)酢酸 (1)3−(5−アミノ−1,2,4−チアジアゾール−3
−イル)−クマリン4.9gをエタノール40mlに懸濁し、一
規定苛性ソーダ40mlを加える。約60℃の湯浴上15分加温
し、2−(5−アミノ−1,2,4−チアジアゾール−3−
イル)−2(Z)−(2−ヒドロキシベンジリデン)酢
酸のアルカリ溶液を得る。(3) While stirring at room temperature, 9.1 g of O-methylhydroxylamine hydrochloride and 9 g of sodium acetate were added to the above solution,
After stirring for 3 hours, leave overnight at room temperature. Acid sodium sulfite 1.
Add 2 g and concentrate under reduced pressure to about 150 ml. Add 200 ml of methyl ethyl ketone and add 10 ml of concentrated hydrochloric acid while stirring under ice cooling. The aqueous layer is extracted twice with 100 ml of methyl ethyl ketone, the organic layers are combined and dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, and the crystals obtained are triturated with a small amount of ethyl acetate and collected by filtration. The second crystals obtained by concentrating the mother liquor are combined to obtain 10.2 g of the title compound. m.p178 ℃
(Disassembly) NMR spectrum (d 6 -DMSO) δ: 3.97 (3H, s), 8.10 (2H,
br.s) Example 3 2- (5-amino-1,2,4-thiadiazol-3-yl) -2 (Z)-(2-ethoxycarbonyloxybenzylidene) acetic acid 3- (5-amino-1, Suspension of 4.9 g of 2,4-thiadiazol-3-yl) -coumarin in 40 ml of ethanol, and addition of 40 ml of 1N caustic soda. Heat on a hot water bath at about 60 ℃ for 15 minutes,
A solution of 2- (5-amino-1,2,4-thiadiazol-3-yl) -2 (Z)-(2-hydroxybenzylidene) -acetic acid disodium salt is obtained. To this, 2.2 g of ethyl chloroformate was added under ice-cooling under ice-cooling, and the mixture was stirred under ice-cooling for 10 minutes. Add 60 ml of ethyl acetate and 20 ml of 1N hydrochloric acid and stir vigorously. The ethyl acetate layer is separated, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The crystals are triturated with ether and filtered to obtain 4.6 g of the title compound. mp 175
℃ (decomposition) Elemental analysis value: Calculated as C 14 H 13 N 3 O 5 S (%): C, 50.14; H, 3.91; N, 12.53 Measured value (%): C, 49.63; H, 3.84; N , 12.30 NMR spectrum (d 6 -DMSO) δ: 1.32 (3H, t, J = 7.5Hz),
4.30 (2H, q, J = 7.5Hz), 7.20 ~ 7.80 (4H, m), 7.55 (1H,
s), 8.00 (2H, s) Example 4 2- (5-amino-1,2,4-thiadiazol-3-yl) -2 (Z)-(2-acetoxybenzylidene) acetic acid (1) 3- ( 5-amino-1,2,4-thiadiazole-3
-Yl) -Coumarin 4.9 g is suspended in 40 ml of ethanol, and 40 ml of 1N caustic soda is added. Warm for 15 minutes on a hot water bath at about 60 ° C to give 2- (5-amino-1,2,4-thiadiazole-3-
An alkaline solution of (yl) -2 (Z)-(2-hydroxybenzylidene) acetic acid is obtained.
(2)ついで上記溶液に氷冷下無水酢酸2.2gを加え、5
分間氷冷下に攪拌する。酢酸エチル60ml,一規定塩酸20m
lを加え激しく攪拌する。酢酸エチル層を分取し、無水
硫酸マグネシウムで乾燥し、減圧下に溶媒を留去する。
結晶をエーテルでほぐしてろ取し、標記化合物4.8gを得
る。(2) Then, 2.2 g of acetic anhydride was added to the above solution under ice cooling, and 5
Stir under ice cooling for 1 minute. Ethyl acetate 60 ml, 1N hydrochloric acid 20 m
Add l and stir vigorously. The ethyl acetate layer is separated, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure.
The crystals are triturated with ether and collected by filtration to obtain 4.8 g of the title compound.
m.p 186−187℃(分解) 元素分析値:C13H11N3O4Sとして 計算値(%):C,51.14; H,3.63; N,13.76 実測値(%):C,51.06; H,3.51; N,13.58 NMRスペクトル(d6−DMSO)δ:2.33(3H,s),7.03〜7.7
3(4H,m),7.50(1H,s),7.93(2H,s) 実施例5 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−2−オキソ酢酸 (1)3−(5−アミノ−1,2,4−チアジアゾール−3
−イル)クマリン2.45g,一規定苛性ソーダ20ml,エタノ
ール20mlからなる混合物を50℃,30分間攪拌し、2−
(5−アミノ−1,2,4−チアジアゾール−3−イル)−
2(Z)−(2−ヒドロキシベンジリデン)酢酸のアル
カリ溶液を得る。mp 186-187 ℃ (decomposition) Elemental analysis value: Calculated as C 13 H 11 N 3 O 4 S (%): C, 51.14; H, 3.63; N, 13.76 Measured value (%): C, 51.06; H , 3.51; N, 13.58 NMR spectrum (d 6 -DMSO) δ: 2.33 (3H, s), 7.03 to 7.7
3 (4H, m), 7.50 (1H, s), 7.93 (2H, s) Example 5 2- (5-Amino-1,2,4-thiadiazol-3-yl) -2-oxoacetic acid (1) 3- (5-amino-1,2,4-thiadiazole-3
-Yl) Coumarin 2.45 g, 1N caustic soda 20 ml, ethanol 20 ml A mixture was stirred for 30 minutes at 50 ℃,
(5-amino-1,2,4-thiadiazol-3-yl)-
An alkaline solution of 2 (Z)-(2-hydroxybenzylidene) acetic acid is obtained.
(2)ついで氷冷下にクロル炭酸エチル1.1gを添加し、
氷冷下に10分攪拌する。ジクロルメタン40mlを加え、つ
いで一規定塩酸10mlで中和し、2−(5−アミノ−1,2,
4−チアジアゾール−3−イル)−2(Z)−(2−エ
トキシカルボニルオキシベンジリデン)酢酸のジクロル
メタン溶液を得る。(2) Then add 1.1 g of ethyl chlorocarbonate under ice cooling,
Stir under ice cooling for 10 minutes. 40 ml of dichloromethane was added, and then neutralized with 10 ml of 1N hydrochloric acid to give 2- (5-amino-1,2,
A solution of 4-thiadiazol-3-yl) -2 (Z)-(2-ethoxycarbonyloxybenzylidene) acetic acid in dichloromethane is obtained.
(3)このジクロルメタン溶液をドライアイス−アセト
ン浴(−78℃)にて冷却しながらオゾンを通じる。青く
なった溶液に酢酸ソーダ0.82gを加え、窒素で瀑気した
後、水20mlを加え激しく攪拌する。水層を分取し、酢酸
エチルで洗った後、ポリスチレン樹脂アンバーライトXA
D−2を用いるカラムクロマトグラフィーに付し、水で
溶出する。溶出液を濃縮した後、凍結乾燥して2−(5
−アミノ−1,2,4−チアジアゾール−3−イル)−2−
オキソ酢酸ナトリウム塩1.6gを得る。(3) Ozone is passed while cooling this dichloromethane solution in a dry ice-acetone bath (-78 ° C). 0.82 g of sodium acetate is added to the bluish solution, the mixture is degassed with nitrogen, 20 ml of water is added, and the mixture is vigorously stirred. The aqueous layer was separated and washed with ethyl acetate, then polystyrene resin Amberlite XA
Subject to column chromatography using D-2 and elute with water. After concentrating the eluate, lyophilize it to give 2- (5
-Amino-1,2,4-thiadiazol-3-yl) -2-
1.6 g of sodium oxoacetate is obtained.
元素分析値:C4H2N3O3SNal.5H2Oとして 計算値(%):C,21.63; H,2.27; N,18.91 実測値(%):C,21.83; H,2.34; N,15.03 (4)2−(5−アミノ−1,2,4−チアジアゾール−3
−イル)−2−オキソ酢酸ナトリウム320mgを氷2mlに溶
解し、氷冷下に一規定塩酸mlを加える。凍結乾燥した
後、メタノール6mlを加え、ろ過する。ろ液を濃縮し、
エーテルを加えた後ろ取して2−(5−アミノ−1,2,4
−チアジアゾール−3−イル)−2−オキソ酢酸200mg
を得る。 Elemental analysis value: Calculated as C 4 H 2 N 3 O 3 SNal.5H 2 O (%): C, 21.63; H, 2.27; N, 18.91 Measured value (%): C, 21.83; H, 2.34; N , 15.03 (4) 2- (5-amino-1,2,4-thiadiazole-3
-Yl) -Sodium 2-oxoacetate (320 mg) is dissolved in ice (2 ml), and 1N hydrochloric acid (ml) is added under ice cooling. After freeze-drying, add 6 ml of methanol and filter. Concentrate the filtrate,
2- (5-amino-1,2,4
-Thiadiazol-3-yl) -2-oxoacetic acid 200 mg
To get
Claims (1)
す]で表わされる化合物またはその塩を塩基の存在下に
加水分解し、ついでアシル化反応または/および中和反
応に付し、得られる一般式 [式中、環Aは前記と同意義、R1は水素原子またはアシ
ル基を示す]で表わされる化合物を酸化反応に付し、得
られる式 で表わされる化合物またはその塩と一般式 R2ONH2 [式中、R2は水素原子または置換されていてもよい炭化
水素基を示す]で表わされる化合物またはその塩とを反
応させることを特徴とする一般式 [式中の記号は前記と同意義]で表わされる化合物また
はその塩の製造方法。1. A general formula [Wherein ring A represents an optionally substituted benzene ring] or a salt thereof is hydrolyzed in the presence of a base, and then subjected to an acylation reaction and / or a neutralization reaction to obtain General formula [Wherein, ring A has the same meaning as defined above, R 1 represents a hydrogen atom or an acyl group], and the compound is obtained by subjecting it to an oxidation reaction. Characterized by reacting a compound represented by or a salt thereof with a compound represented by the general formula R 2 ONH 2 [wherein R 2 represents a hydrogen atom or an optionally substituted hydrocarbon group] or a salt thereof. General formula A method for producing a compound represented by the formula [wherein the symbols are as defined above] or a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4769486A JPH0696562B2 (en) | 1986-03-04 | 1986-03-04 | Process for producing aminothiadiazoleacetic acid derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4769486A JPH0696562B2 (en) | 1986-03-04 | 1986-03-04 | Process for producing aminothiadiazoleacetic acid derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62205066A JPS62205066A (en) | 1987-09-09 |
| JPH0696562B2 true JPH0696562B2 (en) | 1994-11-30 |
Family
ID=12782389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4769486A Expired - Fee Related JPH0696562B2 (en) | 1986-03-04 | 1986-03-04 | Process for producing aminothiadiazoleacetic acid derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0696562B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625187B2 (en) * | 1986-12-10 | 1994-04-06 | エーザイ株式会社 | Thiadiazole derivative |
-
1986
- 1986-03-04 JP JP4769486A patent/JPH0696562B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62205066A (en) | 1987-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MC1921A1 (en) | ACYL DERIVATIVES | |
| US4695639A (en) | Thiazole derivatives | |
| JPH0553798B2 (en) | ||
| JP2708724B2 (en) | Amino-beta-lactamates and their preparation | |
| JPH0696562B2 (en) | Process for producing aminothiadiazoleacetic acid derivative | |
| KR880001775B1 (en) | Process for preparing derivatives of cephalosporins substituted in 3 position by a thiomethyl heterocycle group | |
| CA1236089A (en) | Ceftazidime | |
| KR890002107B1 (en) | Method for preparing cephalosporin derivative | |
| DE2619243C2 (en) | Process for the preparation of 3-acyloxymethyl-cephem compounds | |
| JPH02160791A (en) | Production of cephalosporin derivative | |
| JP2595605B2 (en) | Method for producing 2-substituted oxyimino-3-oxobutyric acid | |
| CA1216841A (en) | Cephalosporin derivatives, their production and use | |
| JPH021835B2 (en) | ||
| US4237280A (en) | Intermediate for cephalosporin type compound | |
| JPH06211820A (en) | Production of aminothiadiazolyl acid halide derivative | |
| JPS6322585A (en) | Production of 6-trifuluoromethyl-1h-benzotriazole-1-yl- diphnylphosphate and cephalosporine derivative | |
| JP2859630B2 (en) | Method for producing thiadiazolylacetic acid derivative and intermediate thereof | |
| JPS5824589A (en) | Biologically active hydrazonocephem derivative | |
| AT358735B (en) | METHOD FOR PRODUCING CEPHEM CONNECTIONS | |
| JPS6056717B2 (en) | N,N-dimethylacetamide adduct of cephalosporin and its production method | |
| KR890000523B1 (en) | Process for preparing cephalosporin derivatives | |
| KR810000635B1 (en) | Process for preparing cephalosporin compounds | |
| KR930007813B1 (en) | Pyridone alkenyl cephalosporins and preparation method thereof | |
| JPS6034974A (en) | Production of cephalosporin compound | |
| JPS59225192A (en) | Cephalosporin ester derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |